Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in Int J Tuberc Lung Dis

Retrieve available abstracts of 596 articles:
HTML format
Text format



Single Articles


    May 2017
  1. ARSCOTT-MILLS T, Masole L, Ncube R, Steenhoff AP, et al
    Survey of health care worker knowledge about childhood tuberculosis in high-burden centers in Botswana.
    Int J Tuberc Lung Dis. 2017;21:586-591.
    PubMed     Text format     Abstract available


  2. SCOTT C, Mangan J, Tillova Z, Jensen PA, et al
    Evaluation of the Tuberculosis Infection Control Training Center, Tajikistan, 2014-2015.
    Int J Tuberc Lung Dis. 2017;21:579-585.
    PubMed     Text format     Abstract available


  3. ADAMS LV, Basu D, Grande SW, Craig SR, et al
    Barriers to tuberculosis care delivery among miners and their families in South Africa: an ethnographic study.
    Int J Tuberc Lung Dis. 2017;21:571-578.
    PubMed     Text format     Abstract available


  4. UKWAJA KN, Alobu I, Gidado M, Onazi O, et al
    Economic support intervention improves tuberculosis treatment outcomes in rural Nigeria.
    Int J Tuberc Lung Dis. 2017;21:564-570.
    PubMed     Text format     Abstract available


  5. LOVEDAY M, Ramjee A, Osburn G, Master I, et al
    Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.
    Int J Tuberc Lung Dis. 2017;21:556-563.
    PubMed     Text format     Abstract available


  6. DALE KD, Globan M, Tay EL, Trauer JM, et al
    Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014.
    Int J Tuberc Lung Dis. 2017;21:550-555.
    PubMed     Text format     Abstract available


  7. MAHARAJ B, Gengiah TN, Yende-Zuma N, Gengiah S, et al
    Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
    Int J Tuberc Lung Dis. 2017;21:537-543.
    PubMed     Text format     Abstract available


  8. SSENGOOBA W, Lukoye D, Meehan CJ, Kateete DP, et al
    Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.
    Int J Tuberc Lung Dis. 2017;21:531-536.
    PubMed     Text format     Abstract available


  9. SATAKE Y, Nakamura Y, Kono M, Hozumi H, et al
    Type-1 polarised dendritic cells are a potent immunogen against Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:523-530.
    PubMed     Text format     Abstract available


  10. RONALD LA, Ling DI, FitzGerald JM, Schwartzman K, et al
    Validated methods for identifying tuberculosis patients in health administrative databases: systematic review.
    Int J Tuberc Lung Dis. 2017;21:517-522.
    PubMed     Text format     Abstract available


  11. FENG JY, Jarlsberg LG, Rose J, Grinsdale JA, et al
    Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.
    Int J Tuberc Lung Dis. 2017;21:509-516.
    PubMed     Text format     Abstract available


  12. HO J, Jelfs P, Nguyen PT, Sintchenko V, et al
    Pooling sputum samples to improve the feasibility of Xpert(R) MTB/RIF in systematic screening for tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:503-508.
    PubMed     Text format     Abstract available


  13. VAN AART C, Boshuizen H, Dekkers A, Korthals Altes H, et al
    Time lag between immigration and tuberculosis rates in immigrants in the Netherlands: a time-series analysis.
    Int J Tuberc Lung Dis. 2017;21:486-492.
    PubMed     Text format     Abstract available


  14. POSEY DL, Marano N, Cetron MS
    Cross-border solutions needed to address tuberculosis in migrating populations.
    Int J Tuberc Lung Dis. 2017;21:485-486.
    PubMed     Text format    


  15. YATES TA, Atkinson SH
    Ironing out sex differences in tuberculosis prevalence.
    Int J Tuberc Lung Dis. 2017;21:483-484.
    PubMed     Text format    


    April 2017
  16. JAIN A, Singh PK, Singh U, Kumar V, et al
    Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Int J Tuberc Lung Dis. 2017;21:478-480.
    PubMed     Text format    


  17. CHONG SG, Herron M, Dorman A, Little M, et al
    Renal amyloidosis complicating multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:476-477.
    PubMed     Text format    


  18. BLOK L, Bakker MI, Straetemans M, Gerstel L, et al
    Should active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:475.
    PubMed     Text format    


  19. WEBER SF, Belard S, Rai S, Reddy R, et al
    Immune thrombocytopenia secondary to tuberculosis: a case and review of literature.
    Int J Tuberc Lung Dis. 2017;21:466-470.
    PubMed     Text format     Abstract available


  20. VALENCIA S, Respeito D, Blanco S, Ribeiro RM, et al
    Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhica.
    Int J Tuberc Lung Dis. 2017;21:446-451.
    PubMed     Text format     Abstract available


  21. ADLER H, Archary M, Mahabeer P, LaRussa P, et al
    Tuberculosis in HIV-infected South African children with complicated severe acute malnutrition.
    Int J Tuberc Lung Dis. 2017;21:438-445.
    PubMed     Text format     Abstract available


  22. CARTER KL, Gabrellas AD, Shah S, Garland JM, et al
    Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist.
    Int J Tuberc Lung Dis. 2017;21:432-437.
    PubMed     Text format     Abstract available


  23. ARMENTA RF, Collins KM, Strathdee SA, Bulterys MA, et al
    Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.
    Int J Tuberc Lung Dis. 2017;21:425-431.
    PubMed     Text format     Abstract available


  24. SHAIKH N, Gupte A, Dharmshale S, Pokkali S, et al
    Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.
    Int J Tuberc Lung Dis. 2017;21:412-419.
    PubMed     Text format     Abstract available


  25. VAN WYK SS, Lin HH, Claassens MM
    A systematic review of prediction models for prevalent pulmonary tuberculosis in adults.
    Int J Tuberc Lung Dis. 2017;21:405-411.
    PubMed     Text format     Abstract available


  26. OWUSU-EDUSEI K, Marks SM, Miramontes R, Stockbridge EL, et al
    Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.
    Int J Tuberc Lung Dis. 2017;21:398-404.
    PubMed     Text format     Abstract available


  27. RUPERT S, Vassall A, Raizada N, Khaparde SD, et al
    Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.
    Int J Tuberc Lung Dis. 2017;21:375-380.
    PubMed     Text format     Abstract available


  28. PANDEY S, Chadha VK, Laxminarayan R, Arinaminpathy N, et al
    Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach.
    Int J Tuberc Lung Dis. 2017;21:366-374.
    PubMed     Text format     Abstract available


  29. DODD PJ
    Tracking tuberculosis incidence: time to tool up.
    Int J Tuberc Lung Dis. 2017;21:363.
    PubMed     Text format    


    March 2017
  30. ZHANG ZX, Sng LH, Yong Y, Lin LM, et al
    Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia.
    Int J Tuberc Lung Dis. 2017 Mar 16. doi: 10.5588/ijtld.16.0667.
    PubMed     Text format     Abstract available


  31. MASJEDI MR, Hosseini M, Aryanpur M, Mortaz E, et al
    The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:351-356.
    PubMed     Text format     Abstract available


  32. BOONYAGARS L, Hirunwiwatkul P, Hurst CP
    CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Int J Tuberc Lung Dis. 2017;21:338-344.
    PubMed     Text format     Abstract available


  33. DIAS M, Gaio R, Sousa P, Abranches M, et al
    Tuberculosis among the homeless: should we change the strategy?
    Int J Tuberc Lung Dis. 2017;21:327-332.
    PubMed     Text format     Abstract available


  34. O'HARA LM, Yassi A, Bryce EA, van Rensburg AJ, et al
    Infection control and tuberculosis in health care workers: an assessment of 28 hospitals in South Africa.
    Int J Tuberc Lung Dis. 2017;21:320-326.
    PubMed     Text format     Abstract available


  35. HUERGA H, Bastard M, Kamene M, Wanjala S, et al
    Outcomes from the first multidrug-resistant tuberculosis programme in Kenya.
    Int J Tuberc Lung Dis. 2017;21:314-319.
    PubMed     Text format     Abstract available


  36. JAVAID A, Hasan R, Zafar A, Chaudry MA, et al
    Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Int J Tuberc Lung Dis. 2017;21:303-308.
    PubMed     Text format     Abstract available


  37. FOX GJ, Anh NT, Nhung NV, Loi NT, et al
    Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:297-302.
    PubMed     Text format     Abstract available


  38. KAMAKIA R, Kiazyk S, Waruk J, Meyers A, et al
    Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:278-285.
    PubMed     Text format     Abstract available


  39. NAUSCH N, Lundtoft C, Schulz G, Henckel H, et al
    Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:270-277.
    PubMed     Text format     Abstract available


  40. DONNAN EJ, Coulter C, Simpson G, Clark J, et al
    Paediatric tuberculosis in Queensland, Australia: overrepresentation of cross-border and Indigenous children.
    Int J Tuberc Lung Dis. 2017;21:263-269.
    PubMed     Text format     Abstract available


  41. CRANMER LM, Langat A, Ronen K, McGrath CJ, et al
    Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.
    Int J Tuberc Lung Dis. 2017;21:256-262.
    PubMed     Text format     Abstract available


  42. REICHMAN LB
    The tuberculosis taboo.
    Int J Tuberc Lung Dis. 2017;21:251-255.
    PubMed     Text format     Abstract available


    February 2017
  43. PRIYADARSHINI P, Tiwari K, Das A, Kumar D, et al
    Evaluation of highly conserved hsp65-specific nested PCR primers for diagnosing Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:214-217.
    PubMed     Text format     Abstract available


  44. MCEBULA V, Crowther NJ, Nagel SE, George JA, et al
    Diabetes and abnormal glucose tolerance in subjects with tuberculosis in a South African urban center.
    Int J Tuberc Lung Dis. 2017;21:208-213.
    PubMed     Text format     Abstract available


  45. BRYLA M, Dziankowska-Zaborszczyk E, Maniecka-Bryla I
    Standard expected years of life lost due to tuberculosis in Poland.
    Int J Tuberc Lung Dis. 2017;21:202-207.
    PubMed     Text format     Abstract available


  46. CLAASSENS MM, Dunbar R, Yang B, Lombard CJ, et al
    Scanty smears associated with initial loss to follow-up in South African tuberculosis patients.
    Int J Tuberc Lung Dis. 2017;21:196-201.
    PubMed     Text format     Abstract available


  47. IZUMI K, Ohkado A, Uchimura K, Kawatsu L, et al
    Evaluation of tuberculosis contact investigations in Japan.
    Int J Tuberc Lung Dis. 2017;21:188-195.
    PubMed     Text format     Abstract available


  48. HTET KK, Liabsuetrakul T, Thein S
    Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar.
    Int J Tuberc Lung Dis. 2017;21:181-187.
    PubMed     Text format     Abstract available


  49. GUGLIELMETTI L, Hewison C, Avaliani Z, Hughes J, et al
    Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
    Int J Tuberc Lung Dis. 2017;21:167-174.
    PubMed     Text format     Abstract available


  50. CHIPINDURO M, Mateveke K, Makamure B, Ferrand RA, et al
    Stool Xpert(R) MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis at primary clinics in Zimbabwe.
    Int J Tuberc Lung Dis. 2017;21:161-166.
    PubMed     Text format     Abstract available


  51. CHIANG SS, Roche S, Contreras C, Del Castillo H, et al
    Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.
    Int J Tuberc Lung Dis. 2017;21:154-160.
    PubMed     Text format     Abstract available


  52. LOPEZ C, Bertram-Farough A, Heywood D, Dawson L, et al
    Knowing about you: eliciting dimensions of personhood within tuberculosis care.
    Int J Tuberc Lung Dis. 2017;21:149-153.
    PubMed     Text format     Abstract available


  53. PARENT SN, Ehrlich R, Baxter V, Kannemeyer N, et al
    Participatory theatre and tuberculosis: a feasibility study with South African health care workers.
    Int J Tuberc Lung Dis. 2017;21:140-148.
    PubMed     Text format     Abstract available


  54. STAGG HR, Lipman MC, McHugh TD, Jenkins HE, et al
    Isoniazid-resistant tuberculosis: a cause for concern?
    Int J Tuberc Lung Dis. 2017;21:129-139.
    PubMed     Text format     Abstract available


    January 2017
  55. RIEDER HL, Van Deun A
    Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:123-124.
    PubMed     Text format    


  56. REVES R, Benjamin R
    The cost of the failure to eliminate tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2017;21:120.
    PubMed     Text format    


  57. KUMAR NP, Velayutham B, Nair D, Babu S, et al
    Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:93-99.
    PubMed     Text format     Abstract available


  58. DAVIS A, Terlikbayeva A, Aifah A, Hermosilla S, et al
    Risks for tuberculosis in Kazakhstan: implications for prevention.
    Int J Tuberc Lung Dis. 2017;21:86-92.
    PubMed     Text format     Abstract available


  59. SHAWENO D, Shaweno T, Trauer JM, Denholm JT, et al
    Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.
    Int J Tuberc Lung Dis. 2017;21:79-85.
    PubMed     Text format     Abstract available


  60. KOURA KG, Trebucq A, Schwoebel V
    Do active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:73-78.
    PubMed     Text format     Abstract available


  61. RUDOLF F, Wagner AJ, Back FM, Gomes VF, et al
    Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR.
    Int J Tuberc Lung Dis. 2017;21:67-72.
    PubMed     Text format     Abstract available


  62. RAGONNET R, Trauer JM, McBryde ES, Houben RM, et al
    Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.
    Int J Tuberc Lung Dis. 2017;21:60-66.
    PubMed     Text format     Abstract available


  63. CHABALA C, Chongwe G, Jumbe-Marsden E, Somwe SW, et al
    Missed opportunities for screening child contacts of smear-positive tuberculosis in Zambia, a high-prevalence setting.
    Int J Tuberc Lung Dis. 2017;21:53-59.
    PubMed     Text format     Abstract available


  64. EGERE U, Togun T, Sillah A, Mendy F, et al
    Identifying children with tuberculosis among household contacts in The Gambia.
    Int J Tuberc Lung Dis. 2017;21:46-52.
    PubMed     Text format     Abstract available


  65. ZELDOW B, Kim S, McSherry G, Cotton MF, et al
    Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
    Int J Tuberc Lung Dis. 2017;21:38-45.
    PubMed     Text format     Abstract available


  66. JERENE D, Abebe W, Taye K, Suarez PG, et al
    Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:32-37.
    PubMed     Text format     Abstract available


  67. TUPASI T, Garfin AM, Mangan JM, Orillaza-Chi R, et al
    Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
    Int J Tuberc Lung Dis. 2017;21:23-31.
    PubMed     Text format     Abstract available


  68. WELDEGEBREAL S, Mebrahtu T
    Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Int J Tuberc Lung Dis. 2017;21:18-22.
    PubMed     Text format     Abstract available


  69. BANU S, Rahman MT, Ahmed S, Khatun R, et al
    Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Int J Tuberc Lung Dis. 2017;21:12-17.
    PubMed     Text format     Abstract available


  70. NOURZAD S, Jenkins HE, Milstein M, Mitnick CD, et al
    Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:6-11.
    PubMed     Text format     Abstract available


  71. FURIN J, Diacon AH, Andries K
    Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Int J Tuberc Lung Dis. 2017;21:4-5.
    PubMed     Text format    


    December 2016
  72. STURKENBOOM MG, Bolhuis MS, Akkerman OW, de Lange WC, et al
    Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements.
    Int J Tuberc Lung Dis. 2016;20:1695-1696.
    PubMed     Text format    


  73. VELAYUTHAM B, Nair D, Kannan T, Padmapriyadarsini C, et al
    Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1671-1676.
    PubMed     Text format     Abstract available


  74. SINGANAYAGAM A, Manalan K, Connell DW, Chalmers JD, et al
    Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1653-1660.
    PubMed     Text format     Abstract available


  75. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  76. CONNERS E, Garfein RS, Rodwell TC, Udwadia ZF, et al
    Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1633-1638.
    PubMed     Text format     Abstract available


  77. ZELNICK JR, O'Donnell MR, Ahuja SD, Chua A, et al
    Health care provider perspectives on tuberculosis care for foreign-born populations in New York City.
    Int J Tuberc Lung Dis. 2016;20:1625-1632.
    PubMed     Text format     Abstract available


  78. BRIGHT-THOMAS RJ, Gondker AR, Morris J, Ormerod LP, et al
    Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
    Int J Tuberc Lung Dis. 2016;20:1621-1624.
    PubMed     Text format     Abstract available


  79. RENDELL NL, Batjargal N, Jadambaa N, Dobler CC, et al
    Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence.
    Int J Tuberc Lung Dis. 2016;20:1615-1620.
    PubMed     Text format     Abstract available


  80. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  81. SIROKA A, Law I, Macinko J, Floyd K, et al
    The effect of household poverty on tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1603-1608.
    PubMed     Text format     Abstract available


  82. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 20012011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  83. JENSEN SG, Lillebaek T, Wilcke T, Pedersen MK, et al
    Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark.
    Int J Tuberc Lung Dis. 2016;20:1580-1587.
    PubMed     Text format     Abstract available


  84. CASTRO KG
    Detection and treatment of persons with latent tuberculosis infection: first eliminate the policy-to-practice gap.
    Int J Tuberc Lung Dis. 2016;20:1565.
    PubMed     Text format    


  85. TALAVERA-PAULIN M, Garcia-Morales L, Ruiz-Sanchez BP, Caamal-Ley AD, et al
    Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins.
    Int J Tuberc Lung Dis. 2016;20:1681-1688.
    PubMed     Text format     Abstract available


  86. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON(R)-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  87. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  88. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 2001-2011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  89. BRUGUERAS S, Orcau A, Millet JP, Espinosa L, et al
    Tuberculosis clinical units improve contact tracing.
    Int J Tuberc Lung Dis. 2016;20:1572-1579.
    PubMed     Text format     Abstract available


  90. O'DONNELL MR, Padayatchi N, Metcalfe JZ
    Elucidating the role of clofazimine for the treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:52-57.
    PubMed     Text format     Abstract available


  91. NUERMBERGER E
    Evolving strategies for dose optimization of linezolid for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:48-51.
    PubMed     Text format     Abstract available


  92. STERLING TR
    Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:42-47.
    PubMed     Text format     Abstract available


  93. MURRAY S, Mendel C, Spigelman M
    TB Alliance regimen development for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:38-41.
    PubMed     Text format     Abstract available


  94. GUPTA R, Wells CD, Hittel N, Hafkin J, et al
    Delamanid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:33-37.
    PubMed     Text format     Abstract available


  95. MILSTEIN M, Brzezinski A, Varaine F, Mitnick CD, et al
    (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:18-23.
    PubMed     Text format     Abstract available


    November 2016
  96. DHOLAKIA Y, Mistry N
    Active tuberculosis case finding in a migrant slum community, Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1562.
    PubMed     Text format    


  97. LEVIN A, Sklyuev S, Felker I, Tceymach E, et al
    Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1539-1545.
    PubMed     Text format     Abstract available


  98. PINA RZ, Caleffi-Ferracioli KR, Campanerut-Sa PA, Ghiraldi-Lopez LD, et al
    Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Int J Tuberc Lung Dis. 2016;20:1535-1538.
    PubMed     Text format     Abstract available


  99. ALIPANAH N, Cattamanchi A, Menzies R, Hopewell PC, et al
    Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:1522-1528.
    PubMed     Text format     Abstract available


  100. KIM CH, Lim JK, Lee DH, Yoo SS, et al
    Outcomes of standard and tailored anti-tuberculosis regimens in patients with tuberculous pleural effusion.
    Int J Tuberc Lung Dis. 2016;20:1516-1521.
    PubMed     Text format     Abstract available


  101. IGLECIAS LM, Puga MA, Pompilio MA, Teles SA, et al
    Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Int J Tuberc Lung Dis. 2016;20:1509-1515.
    PubMed     Text format     Abstract available


  102. IZUMI K, Kawatsu L, Ohkado A, Uchimura K, et al
    Evaluating the impact of health resource reconstruction on improving spatial accessibility of tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:1501-1508.
    PubMed     Text format     Abstract available


  103. LOPEZ AL, Aldaba JG, Ama CG, Sylim PG, et al
    Surveillance for tuberculosis in a rural community in The Philippines.
    Int J Tuberc Lung Dis. 2016;20:1495-1500.
    PubMed     Text format     Abstract available


  104. NOESKE J, Nana Yakam A, Abena Foe JL
    Epidemiology of tuberculosis in Cameroon as mirrored in notification data, 2006-2014.
    Int J Tuberc Lung Dis. 2016;20:1489-1494.
    PubMed     Text format     Abstract available


  105. DAFTARY A, Padayatchi N
    Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
    Int J Tuberc Lung Dis. 2016;20:1483-1488.
    PubMed     Text format     Abstract available


  106. MIBEI DJ, Kiarie JW, Wairia A, Kamene M, et al
    Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1477-1482.
    PubMed     Text format     Abstract available


  107. GARCIA-PRATS AJ, du Plessis L, Draper HR, Burger A, et al
    Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:1469-1476.
    PubMed     Text format     Abstract available


  108. CHAYA S, Dangor Z, Solomon F, Nzenze SA, et al
    Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011.
    Int J Tuberc Lung Dis. 2016;20:1457-1462.
    PubMed     Text format     Abstract available


  109. TURKOVA A, Chappell E, Chalermpantmetagul S, Negra MD, et al
    Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
    Int J Tuberc Lung Dis. 2016;20:1448-1456.
    PubMed     Text format     Abstract available


  110. JAGANATH D, Lamichhane G, Shah M
    Carbapenems against Mycobacterium tuberculosis: a review of the evidence.
    Int J Tuberc Lung Dis. 2016;20:1436-1447.
    PubMed     Text format     Abstract available


  111. UPLEKAR M
    Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Int J Tuberc Lung Dis. 2016;20:1424-1429.
    PubMed     Text format     Abstract available


    October 2016
  112. NUNN A, Tweed C
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:1418-1419.
    PubMed     Text format    


  113. KARAKAS A, Turhan V, Esquinas AM
    Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:1416-1417.
    PubMed     Text format    


  114. FRIEDEN TR
    Positive bacteriological results among contacts of patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1416.
    PubMed     Text format    


  115. NAIDOO P, Dunbar R, du Toit E, van Niekerk M, et al
    Comparing laboratory costs of smear/culture and Xpert(R) MTB/RIF-based tuberculosis diagnostic algorithms.
    Int J Tuberc Lung Dis. 2016;20:1377-1385.
    PubMed     Text format     Abstract available


  116. ZHAO Q, Xiao X, Lu W, Qiu LX, et al
    Screening diabetes in tuberculosis patients in eastern rural China: a community-based cross-sectional study.
    Int J Tuberc Lung Dis. 2016;20:1370-1376.
    PubMed     Text format     Abstract available


  117. WATTANAPOKAYAKIT S, Mushiroda T, Yanai H, Wichukchinda N, et al
    NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Int J Tuberc Lung Dis. 2016;20:1364-1369.
    PubMed     Text format     Abstract available


  118. THIEL BA, Bark CM, Nakibali JG, van der Kuyp F, et al
    Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1358-1363.
    PubMed     Text format     Abstract available


  119. PARCHURE R, Kulkarni V, Gangakhedkar R, Swaminathan S, et al
    Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Int J Tuberc Lung Dis. 2016;20:1348-1353.
    PubMed     Text format     Abstract available


  120. TOLLEFSON D, Ngari F, Mwakala M, Gethi D, et al
    Under-reporting of sputum smear-positive tuberculosis cases in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1334-1341.
    PubMed     Text format     Abstract available


  121. SENKORO M, Kumar AM, Chinnakali P, Mfinanga SG, et al
    Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.
    Int J Tuberc Lung Dis. 2016;20:1326-1333.
    PubMed     Text format     Abstract available


  122. ENANE LA, Lowenthal ED, Arscott-Mills T, Matlhare M, et al
    Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Int J Tuberc Lung Dis. 2016;20:1320-1325.
    PubMed     Text format     Abstract available


  123. STILLSON CH, Okatch H, Frasso R, Mazhani L, et al
    'That's when I struggle' ... Exploring challenges faced by care givers of children with tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2016;20:1314-1319.
    PubMed     Text format     Abstract available


  124. SULIS G, Gnanou S, Roggi A, Konseimbo A, et al
    Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso.
    Int J Tuberc Lung Dis. 2016;20:1306-1308.
    PubMed     Text format     Abstract available


  125. MUNANG ML, Browne C, Evans JT, Smith EG, et al
    Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.
    Int J Tuberc Lung Dis. 2016;20:1300-1305.
    PubMed     Text format     Abstract available


  126. TEBRUEGGE M, Buonsenso D, Brinkmann F, Noguera-Julian A, et al
    European shortage of purified protein derivative and its impact on tuberculosis screening practices.
    Int J Tuberc Lung Dis. 2016;20:1293-1299.
    PubMed     Text format     Abstract available


  127. TREBUCQ A, Schwoebel V
    Numbers of tuberculosis cases: dreams and reality.
    Int J Tuberc Lung Dis. 2016;20:1288-1292.
    PubMed     Text format     Abstract available


  128. LONG R, Lau A
    How R G Ferguson's groundbreaking studies influenced our understanding of tuberculosis reinfection. Where to next?
    Int J Tuberc Lung Dis. 2016;20:1285-1287.
    PubMed     Text format    


  129. LONNROTH K, Shah NS, Lange C
    State-of-the-art series on tuberculosis and migration.
    Int J Tuberc Lung Dis. 2016;20:1280-1281.
    PubMed     Text format    


    September 2016
  130. EILERTSON B, Maruri F, Blackman A, Herrera M, et al
    Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1276-7.
    PubMed     Text format    


  131. OTTO-KNAPP R, Vesenbeckh S, Schonfeld N, Bettermann G, et al
    Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.
    Int J Tuberc Lung Dis. 2016;20:1275-6.
    PubMed     Text format    


  132. HEMANTH KUMAR AK, Kannan T, Chandrasekaran V, Sudha V, et al
    Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.
    Int J Tuberc Lung Dis. 2016;20:1236-41.
    PubMed     Text format     Abstract available


  133. PANDE T, Cohen C, Pai M, Ahmad Khan F, et al
    Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:1226-30.
    PubMed     Text format     Abstract available


  134. NUNES C, Taylor BM
    Modelling the time to detection of urban tuberculosis in two big cities in Portugal: a spatial survival analysis.
    Int J Tuberc Lung Dis. 2016;20:1219-25.
    PubMed     Text format     Abstract available


  135. MANGAN JM, Tupasi TE, Garfin AM, Lofranco V, et al
    Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatment.
    Int J Tuberc Lung Dis. 2016;20:1205-11.
    PubMed     Text format     Abstract available


  136. KWEDI NOLNA S, Kammogne ID, Ndzinga R, Afanda B, et al
    Community knowledge, attitudes and practices in relation to tuberculosis in Cameroon.
    Int J Tuberc Lung Dis. 2016;20:1199-204.
    PubMed     Text format     Abstract available


  137. DEMEMEW ZG, Habte D, Melese M, Hamusse SD, et al
    Trends in tuberculosis case notification and treatment outcomes after interventions in 10 zones of Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:1192-8.
    PubMed     Text format     Abstract available


  138. KAPLAN R, Caldwell J, Hermans S, Adriaanse S, et al
    An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town.
    Int J Tuberc Lung Dis. 2016;20:1185-91.
    PubMed     Text format     Abstract available


  139. JENKS JD, Kumarasamy N, Ezhilarasi C, Poongulali S, et al
    Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India.
    Int J Tuberc Lung Dis. 2016;20:1181-4.
    PubMed     Text format     Abstract available


  140. YHI JY, Park DW, Min JH, Park YK, et al
    Measurement of levels of fractional exhaled nitric oxide in patients with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1174-80.
    PubMed     Text format     Abstract available


  141. BHATRAJU P, Patrawalla P, Trieu L, Ahuja SD, et al
    Errors in isolation of patients with infectious tuberculosis at a public teaching hospital in New York.
    Int J Tuberc Lung Dis. 2016;20:1168-73.
    PubMed     Text format     Abstract available


  142. RAO SA, Kadhiravan T, Swaminathan RP, Mahadevan S, et al
    Occupational exposure and tuberculosis among medical residents in a high-burden setting: an open-cohort study.
    Int J Tuberc Lung Dis. 2016;20:1162-7.
    PubMed     Text format     Abstract available


  143. TAYLOR JG, Yates TA, Mthethwa M, Tanser F, et al
    Measuring ventilation and modelling M. tuberculosis transmission in indoor congregate settings, rural KwaZulu-Natal.
    Int J Tuberc Lung Dis. 2016;20:1155-61.
    PubMed     Text format     Abstract available


  144. SUTHAR AB, Zachariah R, Harries AD
    Ending tuberculosis by 2030: can we do it?
    Int J Tuberc Lung Dis. 2016;20:1148-54.
    PubMed     Text format     Abstract available


  145. CHIANG CY, Van Deun A, Rieder HL
    Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1143-7.
    PubMed     Text format     Abstract available


  146. TWEED C, Nunn A
    Occupational exposure to tuberculosis in endemic areas: room for improvement.
    Int J Tuberc Lung Dis. 2016;20:1139.
    PubMed     Text format    


  147. SCARDIGLI A, Caminero JA
    Simple and practical measures to reduce tuberculosis transmission in public buildings.
    Int J Tuberc Lung Dis. 2016;20:1137-8.
    PubMed     Text format    


    August 2016
  148. DAUM LT, Fourie PB, Peters RP, Rodriguez JD, et al
    Xpert((R)) MTB/RIF detection of Mycobacterium tuberculosis from sputum collected in molecular transport medium.
    Int J Tuberc Lung Dis. 2016;20:1118-24.
    PubMed     Text format     Abstract available


  149. ATWEBEMBEIRE J, Orikiriza P, Bonnet M, Atwine D, et al
    Xpert((R)) MTB/RIF for detection of Mycobacterium tuberculosis from frozen string and induced sputum sediments.
    Int J Tuberc Lung Dis. 2016;20:1113-7.
    PubMed     Text format     Abstract available


  150. BOLLELA VR, Namburete EI, Feliciano CS, Macheque D, et al
    Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1099-104.
    PubMed     Text format     Abstract available


  151. MONTGOMERY CM
    Adaptive trials for tuberculosis: early reflections on theory and practice.
    Int J Tuberc Lung Dis. 2016;20:1091-8.
    PubMed     Text format     Abstract available


  152. STRINGER B, Lowton K, Tillashaikhov M, Parpieva N, et al
    'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.
    Int J Tuberc Lung Dis. 2016;20:1084-90.
    PubMed     Text format     Abstract available


  153. TRIASIH R, Padmawati RS, Duke T, Robertson C, et al
    A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia.
    Int J Tuberc Lung Dis. 2016;20:1078-83.
    PubMed     Text format     Abstract available


  154. MARITZ ER, Montepiedra G, Liu L, Mitchell CD, et al
    Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.
    Int J Tuberc Lung Dis. 2016;20:1060-4.
    PubMed     Text format     Abstract available


  155. ADJOBIMEY M, Masserey E, Adjonou C, Gbenagnon G, et al
    Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.
    Int J Tuberc Lung Dis. 2016;20:1055-9.
    PubMed     Text format     Abstract available


  156. FLICK RJ, Kim MH, Simon K, Munthali A, et al
    Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.
    Int J Tuberc Lung Dis. 2016;20:1046-54.
    PubMed     Text format     Abstract available


  157. BRENNAN AT, Bonawitz R, Schnippel K, Berhanu R, et al
    Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa.
    Int J Tuberc Lung Dis. 2016;20:1040-5.
    PubMed     Text format     Abstract available


  158. HENOSTROZA G, Harris JB, Chitambi R, Siyambango M, et al
    High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: need for enhanced screening approach.
    Int J Tuberc Lung Dis. 2016;20:1033-9.
    PubMed     Text format     Abstract available


  159. SOUSA P, Oliveira A, Gomes M, Gaio AR, et al
    Longitudinal clustering of tuberculosis incidence and predictors for the time profiles: the impact of HIV.
    Int J Tuberc Lung Dis. 2016;20:1027-32.
    PubMed     Text format     Abstract available


  160. SUBRAMANI R, Gomathy S, Lakshmi M, Swaminathan S, et al
    Trend in the incidence of smear-positive tuberculosis in a district in South India after DOTS implementation.
    Int J Tuberc Lung Dis. 2016;20:1022-6.
    PubMed     Text format     Abstract available


  161. SENKORO M, Mfinanga S, Egwaga S, Mtandu R, et al
    Prevalence of pulmonary tuberculosis in adult population of Tanzania: a national survey, 2012.
    Int J Tuberc Lung Dis. 2016;20:1014-21.
    PubMed     Text format     Abstract available


  162. SABIITI W, Mtafya B, Kuchaka D, Azam K, et al
    Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
    Int J Tuberc Lung Dis. 2016;20:1004-9.
    PubMed     Text format     Abstract available


  163. ANDRE E, Isaacs C, Affolabi D, Alagna R, et al
    Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.
    Int J Tuberc Lung Dis. 2016;20:999-1003.
    PubMed     Text format     Abstract available


  164. HESSELING AC, Rabie H
    Tuberculosis and HIV remain major causes of death in African children.
    Int J Tuberc Lung Dis. 2016;20:996-7.
    PubMed     Text format    


    July 2016
  165. MAJUMDER A, Carroll B, Bhana S, Tefu D, et al
    Screening for active tuberculosis in a diabetes mellitus clinic in Soweto, South Africa.
    Int J Tuberc Lung Dis. 2016;20:992-3.
    PubMed     Text format    


  166. GERONA R, Wen A, Koss C, Bacchetti P, et al
    A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2016;20:991-2.
    PubMed     Text format    


  167. CASTRO JL
    In reply: The language of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:989-90.
    PubMed     Text format    


  168. DESHMUKH R
    Targeting zero tuberculosis deaths among people living with HIV: a call for action.
    Int J Tuberc Lung Dis. 2016;20:988.
    PubMed     Text format    


  169. LESSEM E, Frick M
    Ensuring availability of the best tuberculosis treatment options in the Philippines.
    Int J Tuberc Lung Dis. 2016;20:988-9.
    PubMed     Text format    


  170. OH KH, Kim HJ, Kim MH
    Non-communicable diseases and risk of tuberculosis in Korea.
    Int J Tuberc Lung Dis. 2016;20:973-7.
    PubMed     Text format     Abstract available


  171. YIN XM, Wu LJ, Zheng L, Mao XR, et al
    Quantification of colony-forming units for M. tuberculosis complex using gyrB-based real-time PCR assay.
    Int J Tuberc Lung Dis. 2016;20:967-72.
    PubMed     Text format     Abstract available


  172. SHIN SS, Chang AH, Ghosh JK, Dube MP, et al
    Isoniazid therapy for Mycobacterium tuberculosis infection in HIV clinics, Los Angeles, California.
    Int J Tuberc Lung Dis. 2016;20:961-6.
    PubMed     Text format     Abstract available


  173. MAZE MJ, Paynter J, Chiu W, Hu R, et al
    Therapeutic drug monitoring of isoniazid and rifampicin during anti-tuberculosis treatment in Auckland, New Zealand.
    Int J Tuberc Lung Dis. 2016;20:955-60.
    PubMed     Text format     Abstract available


  174. CHOI H, Chung H, Muntaner C, Lee M, et al
    The impact of social conditions on patient adherence to pulmonary tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:948-54.
    PubMed     Text format     Abstract available


  175. CASTRO KG, Marks SM, Chen MP, Hill AN, et al
    Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades.
    Int J Tuberc Lung Dis. 2016;20:926-33.
    PubMed     Text format     Abstract available


  176. IBARZ-PAVON AB, Papaventsis D, Kalkouni R, Metaxas G, et al
    Pilot study of the completeness of notification of adult tuberculosis in Athens, Greece.
    Int J Tuberc Lung Dis. 2016;20:920-5.
    PubMed     Text format     Abstract available


  177. PAVLINAC PB, Lokken EM, Walson JL, Richardson BA, et al
    Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:895-902.
    PubMed     Text format     Abstract available


  178. BARES R, Khalid N, Daniel H, Dittmann H, et al
    Hypothyroidism during second-line treatment of multidrug-resistant tuberculosis: a prospective study.
    Int J Tuberc Lung Dis. 2016;20:876-81.
    PubMed     Text format     Abstract available


  179. STAGG HR, Hatherell HA, Lipman MC, Harris RJ, et al
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:866-9.
    PubMed     Text format     Abstract available


  180. DEAN AS, Zignol M, Lumb R, Lalor M, et al
    Sputum smear microscopy result: a predictor for drug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:864-5.
    PubMed     Text format     Abstract available


  181. KOETHE JR, von Reyn CF
    Protein-calorie malnutrition, macronutrient supplements, and tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:857-63.
    PubMed     Text format     Abstract available


    June 2016
  182. BALCELLS ME, Huilcaman M, Pena C, Castillo C, et al
    M. tuberculosis DNA detection in nasopharyngeal mucosa can precede tuberculosis development in contacts.
    Int J Tuberc Lung Dis. 2016;20:848-52.
    PubMed     Text format     Abstract available


  183. MAVE V, Chandanwale A, Kinikar A, Khadse S, et al
    Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.
    Int J Tuberc Lung Dis. 2016;20:844-7.
    PubMed     Text format     Abstract available


  184. SINGH M, Sethi GR, Mantan M, Khanna A, et al
    Xpert((R)) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:839-43.
    PubMed     Text format     Abstract available


  185. JINDANI A, Borgulya G, de Patino IW, Gonzales T, et al
    A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:832-8.
    PubMed     Text format     Abstract available


  186. HOLLAND DP, Hamilton CD, Stout JE
    Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
    Int J Tuberc Lung Dis. 2016;20:827-31.
    PubMed     Text format     Abstract available


  187. MOTA L, Al-Efraij K, Campbell JR, Cook VJ, et al
    Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:819-26.
    PubMed     Text format     Abstract available


  188. CHEN R, Wang J, Tang SW, Zhang Y, et al
    CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Int J Tuberc Lung Dis. 2016;20:812-8.
    PubMed     Text format     Abstract available


  189. DHATWALIA SK, Yadav R, Behera D, Rudramurthy SM, et al
    Distribution and association of Mycobacterium tuberculosis CAS lineage with multidrug resistance in North India.
    Int J Tuberc Lung Dis. 2016;20:806-11.
    PubMed     Text format     Abstract available


  190. LEE SS, Lee CM, Kim TH, Kim JJ, et al
    Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:800-5.
    PubMed     Text format     Abstract available


  191. SANDER MS, Vuchas CY, Numfor HN, Nsimen AN, et al
    Sputum bacterial load predicts multidrug-resistant tuberculosis in retreatment patients: a case-control study.
    Int J Tuberc Lung Dis. 2016;20:793-9.
    PubMed     Text format     Abstract available


  192. JENSENIUS M, Winje BA, Blomberg B, Mengshoel AT, et al
    Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
    Int J Tuberc Lung Dis. 2016;20:786-92.
    PubMed     Text format     Abstract available


  193. MACPHERSON P, Squire SB, Cleary P, Davies S, et al
    Equitable tuberculosis care in the North West of England: analysis of tuberculosis cohort review data.
    Int J Tuberc Lung Dis. 2016;20:778-85.
    PubMed     Text format     Abstract available


  194. CARAFFA E, Schepisi MS, Gualano G, Parracino MP, et al
    The diabetes-tuberculosis co-epidemic: the role of international migration.
    Int J Tuberc Lung Dis. 2016;20:771-7.
    PubMed     Text format     Abstract available


  195. CAMPBELL JR, Krot J, Marra F
    Latent tuberculosis diagnostic tests to predict longitudinal tuberculosis during dialysis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:764-70.
    PubMed     Text format     Abstract available


  196. EVERATT R, Kuzmickiene I, Davidaviciene E, Cicenas S, et al
    Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania.
    Int J Tuberc Lung Dis. 2016;20:757-63.
    PubMed     Text format     Abstract available


  197. LEUNG CC
    Does tuberculosis increase the risk of lung cancer?
    Int J Tuberc Lung Dis. 2016;20:712.
    PubMed     Text format    


    May 2016
  198. BRANAGAN P, Moran B, Fitzgibbon M, Reid V, et al
    Inoculation site leprosy in a tattoo as a paradoxical reaction following tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:706-8.
    PubMed     Text format     Abstract available


  199. ARYANPUR M, Masjedi MR, Hosseini M, Mortaz E, et al
    Cigarette smoking in patients newly diagnosed with pulmonary tuberculosis in Iran.
    Int J Tuberc Lung Dis. 2016;20:679-84.
    PubMed     Text format     Abstract available


  200. YELLAPPA V, Battaglioli T, Gurum SK, Narayanan D, et al
    Private practitioners' contributions to the Revised National Tuberculosis Control Programme in a South Indian district.
    Int J Tuberc Lung Dis. 2016;20:659-65.
    PubMed     Text format     Abstract available


  201. GLOBAN M, Lavender C, Leslie D, Brown L, et al
    Molecular epidemiology of tuberculosis in Victoria, Australia, reveals low level of transmission.
    Int J Tuberc Lung Dis. 2016;20:652-8.
    PubMed     Text format     Abstract available


  202. GURBANOVA E, Mehdiyev R, Blondal K, Altraja A, et al
    Predictors of cure in rifampicin-resistant tuberculosis in prison settings with low loss to follow-up.
    Int J Tuberc Lung Dis. 2016;20:645-51.
    PubMed     Text format     Abstract available


  203. SEIFERT M, Ajbani K, Georghiou SB, Catanzaro D, et al
    A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:631-7.
    PubMed     Text format     Abstract available


  204. PINTO M, Steffen RE, Cobelens F, van den Hof S, et al
    Cost-effectiveness of the Xpert((R)) MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Int J Tuberc Lung Dis. 2016;20:611-8.
    PubMed     Text format     Abstract available


  205. QUISPE R, Valle GA, Huapaya JA, Novoa I, et al
    Manual MGIT system for the detection of Mycobacterium tuberculosis: insights from a high TB burden setting.
    Int J Tuberc Lung Dis. 2016;20:605-10.
    PubMed     Text format     Abstract available


  206. JOHNSON MG, Stout JE, Benator DA, Whitworth WC, et al
    Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements.
    Int J Tuberc Lung Dis. 2016;20:600-4.
    PubMed     Text format     Abstract available


  207. NAKAGGWA P, Odeke R, Kirenga BJ, Bloss E, et al
    Incomplete sputum smear microscopy monitoring among smear-positive tuberculosis patients in Uganda.
    Int J Tuberc Lung Dis. 2016;20:594-9.
    PubMed     Text format     Abstract available


  208. CHUCK C, Robinson E, Macaraig M, Alexander M, et al
    Enhancing management of tuberculosis treatment with video directly observed therapy in New York City.
    Int J Tuberc Lung Dis. 2016;20:588-93.
    PubMed     Text format     Abstract available


  209. NAGAVCI BL, de Gelder R, Martikainen P, Deboosere P, et al
    Inequalities in tuberculosis mortality: long-term trends in 11 European countries.
    Int J Tuberc Lung Dis. 2016;20:574-81.
    PubMed     Text format     Abstract available


  210. CHAULK CP, Belknap R
    A public heath 'selfie' for treating tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:571.
    PubMed     Text format    


  211. VAN RIE A, Taylor R
    Can we translate findings on inequality in tuberculosis mortality into policy?
    Int J Tuberc Lung Dis. 2016;20:569-70.
    PubMed     Text format    


  212. NICOLINI A, Perazzo A, Gatto P, Piroddi IM, et al
    A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.
    Int J Tuberc Lung Dis. 2016;20:704-5.
    PubMed     Text format     Abstract available


  213. MUKHERJEE A, Velpandian T, Singla M, Kanhiya K, et al
    Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Int J Tuberc Lung Dis. 2016;20:666-72.
    PubMed     Text format     Abstract available


  214. RUAN YZ, Li RZ, Wang XX, Wang LX, et al
    The affordability for patients of a new universal MDR-TB coverage model in China.
    Int J Tuberc Lung Dis. 2016;20:638-44.
    PubMed     Text format     Abstract available


  215. MODI M, Sharma K, Sharma M, Sharma A, et al
    Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis.
    Int J Tuberc Lung Dis. 2016;20:625-30.
    PubMed     Text format     Abstract available


  216. MOK Y, Tan TY, Tay TR, Wong HS, et al
    Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert(R) MTB/RIF?
    Int J Tuberc Lung Dis. 2016;20:619-24.
    PubMed     Text format     Abstract available


    April 2016
  217. BRONNER MURRISON L, Ananthakrishnan R, Swaminathan A, Auguesteen S, et al
    How do patients access the private sector in Chennai, India? An evaluation of delays in tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2016;20:544-51.
    PubMed     Text format     Abstract available


  218. MCDOWELL A, Pai M
    Treatment as diagnosis and diagnosis as treatment: empirical management of presumptive tuberculosis in India.
    Int J Tuberc Lung Dis. 2016;20:536-43.
    PubMed     Text format     Abstract available


  219. CALDERON HERNAIZ R, Ruiz Giardin JM, Cabello Clotet N, Canora Lebrato J, et al
    Tuberculosis and immigration in an area of southwest Madrid.
    Int J Tuberc Lung Dis. 2016;20:530-5.
    PubMed     Text format     Abstract available


  220. KIM S, Kim H, Kim WJ, Lee SJ, et al
    Mortality and predictors in pulmonary tuberculosis with respiratory failure requiring mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:524-9.
    PubMed     Text format     Abstract available


  221. DALE K, Tay E, Trevan P, Denholm JT, et al
    Mortality among tuberculosis cases in Victoria, 2002-2013: case fatality and factors associated with death.
    Int J Tuberc Lung Dis. 2016;20:515-23.
    PubMed     Text format     Abstract available


  222. KANAMORI H, Hatakeyama T, Uchiyama B, Weber DJ, et al
    Clinical and molecular epidemiological features of tuberculosis after the 2011 Japan earthquake and tsunami.
    Int J Tuberc Lung Dis. 2016;20:505-14.
    PubMed     Text format     Abstract available


  223. SWAMINATHAN A, du Cros P, Seddon JA, Quinnell S, et al
    Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
    Int J Tuberc Lung Dis. 2016;20:474-8.
    PubMed     Text format     Abstract available


  224. HUANG ZK, Luo Q, Qing C, Deng YT, et al
    Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:468-73.
    PubMed     Text format     Abstract available


  225. LI H, Zhou LP, Luo J, Yu JP, et al
    Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:462-7.
    PubMed     Text format     Abstract available


  226. ZHENG LH, Jia HY, Liu XJ, Sun HS, et al
    Modified cytospin slide microscopy method for rapid diagnosis of smear-negative pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:456-61.
    PubMed     Text format     Abstract available


  227. TAHSEEN S, Qadeer E, Khanzada FM, Rizvi AH, et al
    Use of Xpert((R)) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan.
    Int J Tuberc Lung Dis. 2016;20:448-55.
    PubMed     Text format     Abstract available


  228. MARKS SM, Hirsch-Moverman Y, Salcedo K, Graviss EA, et al
    Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.
    Int J Tuberc Lung Dis. 2016;20:435-41.
    PubMed     Text format     Abstract available


  229. O'DONNELL MR, Daftary A, Frick M, Hirsch-Moverman Y, et al
    Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.
    Int J Tuberc Lung Dis. 2016;20:430-4.
    PubMed     Text format     Abstract available


  230. SOTGIU G, Migliori GB
    TB-related mortality: a re-emerging problem in high-income countries?
    Int J Tuberc Lung Dis. 2016;20:428.
    PubMed     Text format    


  231. BILLO NE
    Costs for TB and MDR-TB: time to convene a WHO Emergency Committee on TB?
    Int J Tuberc Lung Dis. 2016;20:427.
    PubMed     Text format    


  232. BANDA H, Robinson R, Thomson R, Squire SB, et al
    The 'Practical Approach to Lung Health' in sub-Saharan Africa: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:552-9.
    PubMed     Text format     Abstract available


  233. YU J, Wang ZJ, Chen LH, Li HH, et al
    Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:494-9.
    PubMed     Text format     Abstract available


  234. WANG F, Hou HY, Wu SJ, Zhu Q, et al
    Using the TBAg/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area.
    Int J Tuberc Lung Dis. 2016;20:487-93.
    PubMed     Text format     Abstract available


  235. SILVA AP, Hill P, Belo MT, Rabelo SG, et al
    Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil.
    Int J Tuberc Lung Dis. 2016;20:479-86.
    PubMed     Text format     Abstract available


  236. KELLY AM, Smith B, Luo Z, Given B, et al
    Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.
    Int J Tuberc Lung Dis. 2016;20:442-7.
    PubMed     Text format     Abstract available


    March 2016
  237. SHIN SS, Modongo C, Zetola NM
    The impact of mixed infections on the interpretation of molecular epidemiology studies of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:423-4.
    PubMed     Text format    


  238. SARIN P, Duffy J, Mughal Z, Hedayat E, et al
    Vitamin D and tuberculosis: review and association in three rural provinces of Afghanistan.
    Int J Tuberc Lung Dis. 2016;20:383-8.
    PubMed     Text format     Abstract available


  239. LO HY, Yang SL, Lin HH, Bai KJ, et al
    Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:376-82.
    PubMed     Text format     Abstract available


  240. PARR JB, Rich ML, Keshavjee S, Franke MF, et al
    Presumptive treatment of multidrug-resistant tuberculosis in household contacts.
    Int J Tuberc Lung Dis. 2016;20:370-5.
    PubMed     Text format     Abstract available


  241. QIN F, Barry PM, Pascopella L
    Factors associated with extended treatment among tuberculosis patients at risk of relapse in California.
    Int J Tuberc Lung Dis. 2016;20:363-9.
    PubMed     Text format     Abstract available


  242. PAULINO J, Martins A, Machado M, Gomes M, et al
    Tuberculosis in native- and foreign-born populations in Portugal.
    Int J Tuberc Lung Dis. 2016;20:357-62.
    PubMed     Text format     Abstract available


  243. SMITH A, Burger R, Claassens M, Ayles H, et al
    Health care workers' gender bias in testing could contribute to missed tuberculosis among women in South Africa.
    Int J Tuberc Lung Dis. 2016;20:350-6.
    PubMed     Text format     Abstract available


  244. KHAN PY, Glynn JR, Fielding KL, Mzembe T, et al
    Risk factors for Mycobacterium tuberculosis infection in 2-4 year olds in a rural HIV-prevalent setting.
    Int J Tuberc Lung Dis. 2016;20:342-9.
    PubMed     Text format     Abstract available


  245. YU X, Ma YF, Jiang GL, Chen ST, et al
    Sensititre(R) MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
    Int J Tuberc Lung Dis. 2016;20:329-34.
    PubMed     Text format     Abstract available


  246. ZHANG T, Lv CF, Wang J, Zheng WB, et al
    Direct tuberculosis drug susceptibility testing: time-saving and cost-effective in detecting MDR-TB.
    Int J Tuberc Lung Dis. 2016;20:323-8.
    PubMed     Text format     Abstract available


  247. HO J, Nguyen PT, Nguyen TA, Tran HK, et al
    The role of macroscopic sputum quality assessments to optimise sputum testing for tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:319-22.
    PubMed     Text format     Abstract available


  248. HALIM KS, Islam MZ, Fatema N, Khan MD, et al
    Validation of smear-positive tuberculosis diagnoses in Bangladesh.
    Int J Tuberc Lung Dis. 2016;20:314-8.
    PubMed     Text format     Abstract available


  249. MAHESHWARI P, Chauhan K, Kadam R, Pujani A, et al
    Market assessment of tuberculosis diagnostics in India in 2013.
    Int J Tuberc Lung Dis. 2016;20:304-13.
    PubMed     Text format     Abstract available


  250. ZHAO YL, Pang Y, Xia H, Du X, et al
    Market assessment of tuberculosis diagnostics in China in 2012.
    Int J Tuberc Lung Dis. 2016;20:295-303.
    PubMed     Text format     Abstract available


  251. FURIN J, Alirol E, Allen E, Fielding K, et al
    Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
    Int J Tuberc Lung Dis. 2016;20:290-4.
    PubMed     Text format     Abstract available


  252. KAPUR A
    Tuberculosis prevention and control: we need to pay heed to diabetes care.
    Int J Tuberc Lung Dis. 2016;20:287.
    PubMed     Text format    


  253. ZUMLA A, Davies PD
    Progress towards achieving global tuberculosis control: so near, yet so far.
    Int J Tuberc Lung Dis. 2016;20:285-6.
    PubMed     Text format    


  254. KOSGEI RJ, Sitienei JK, Kipruto H, Kimenye K, et al
    In reply.
    Int J Tuberc Lung Dis. 2016;20:425-6.
    PubMed     Text format    


  255. HORTON KC, Houben RM, White RG, Corbett EL, et al
    Time for men to count, too.
    Int J Tuberc Lung Dis. 2016;20:425.
    PubMed     Text format    


  256. COWAN J, Michel C, Manhica I, Mutaquiha C, et al
    Remote monitoring of Xpert(R) MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.
    Int J Tuberc Lung Dis. 2016;20:335-41.
    PubMed     Text format     Abstract available


    February 2016
  257. SHARMA S, Nahar U, Das A, Radotra B, et al
    Acute respiratory distress syndrome in disseminated tuberculosis: an uncommon association.
    Int J Tuberc Lung Dis. 2016;20:271-5.
    PubMed     Text format     Abstract available


  258. FAN WC, Ou SM, Feng JY, Hu YW, et al
    Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease.
    Int J Tuberc Lung Dis. 2016;20:265-70.
    PubMed     Text format     Abstract available


  259. ZWERLING A, Gomez GB, Pennington J, Cobelens F, et al
    A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens.
    Int J Tuberc Lung Dis. 2016;20:257-60.
    PubMed     Text format     Abstract available


  260. CHANDRA TJ, Selvaraj R, Sharma YV
    Same-day sputum smear microscopy for the diagnosis of pulmonary tuberculosis: direct vs. concentrated smear.
    Int J Tuberc Lung Dis. 2016;20:247-51.
    PubMed     Text format     Abstract available


  261. JEENA L, Naidoo K
    Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:235-9.
    PubMed     Text format     Abstract available


  262. NGUYEN DT, Bang ND, Hung NQ, Beasley RP, et al
    Yield of chest radiograph in tuberculosis screening for HIV-infected persons at a district-level HIV clinic.
    Int J Tuberc Lung Dis. 2016;20:211-7.
    PubMed     Text format     Abstract available


  263. NLIWASA M, MacPherson P, Mukaka M, Mdolo A, et al
    High mortality and prevalence of HIV and tuberculosis in adults with chronic cough in Malawi: a cohort study.
    Int J Tuberc Lung Dis. 2016;20:202-10.
    PubMed     Text format     Abstract available


  264. HEYSELL SK, Ogarkov OB, Zhdanova S, Zorkaltseva E, et al
    Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
    Int J Tuberc Lung Dis. 2016;20:187-92.
    PubMed     Text format     Abstract available


  265. LEW WJ, Harrington K, Garfin C, Islam T, et al
    Outcomes of Category I and II regimens in mono- and polyresistant tuberculosis cases in the Philippines.
    Int J Tuberc Lung Dis. 2016;20:170-6.
    PubMed     Text format     Abstract available


  266. MAJUMDAR T, Bhattacharya S, Barman D, Bhoumik P, et al
    Detection of multidrug-resistant tuberculosis using MGIT(TM) and MAS-PCR in Tripura, India.
    Int J Tuberc Lung Dis. 2016;20:166-9.
    PubMed     Text format     Abstract available


  267. GEORGHIOU SB, Ajbani K, Rodrigues C, Rodwell TC, et al
    Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in India.
    Int J Tuberc Lung Dis. 2016;20:160-5.
    PubMed     Text format     Abstract available


  268. MILLAN-LOU MI, Olle-Goig JE, Tortola MT, Martin C, et al
    Mycobacterial diversity causing multi- and extensively drug-resistant tuberculosis in Djibouti, Horn of Africa.
    Int J Tuberc Lung Dis. 2016;20:150-3.
    PubMed     Text format     Abstract available


  269. BOYLES TH, Kengne AP
    A priori estimation of diagnostic thresholds could improve the reporting of diagnostic studies of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:147-9.
    PubMed     Text format    


  270. MITNICK C, van den Hof S
    Using existing data to illustrate-and close-the gap in access to new anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2016;20:145.
    PubMed     Text format    


  271. TAKIFF H, Alame-Emane AK, Pierre-Audigier C, Gicquel B, et al
    In reply.
    Int J Tuberc Lung Dis. 2016;20:282-3.
    PubMed     Text format    


  272. COBELENS F, Gebhard A, van den Hof S
    No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
    Int J Tuberc Lung Dis. 2016;20:282.
    PubMed     Text format    


  273. YANG HK, Park MJ, Lee JH, Lee CT, et al
    Incidence of toxic optic neuropathy with low-dose ethambutol.
    Int J Tuberc Lung Dis. 2016;20:261-4.
    PubMed     Text format     Abstract available


  274. SIDIQ Z, Hanif M, Chopra KK, Khanna A, et al
    Random blinded rechecking of AFB smears in a pilot project at an intermediate reference laboratory.
    Int J Tuberc Lung Dis. 2016;20:252-6.
    PubMed     Text format     Abstract available


  275. MBONZE NB, Tabala M, Wenzi LK, Bakoko B, et al
    Xpert((R)) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.
    Int J Tuberc Lung Dis. 2016;20:240-6.
    PubMed     Text format     Abstract available


  276. SABI I, Kabyemera R, Mshana SE, Kidenya BR, et al
    Pulmonary TB bacteriologically confirmed by induced sputum among children at Bugando Medical Centre, Tanzania.
    Int J Tuberc Lung Dis. 2016;20:228-34.
    PubMed     Text format     Abstract available


  277. ELIAS D, Akuffo H, Abate E, Mekonnen Y, et al
    Risk of tuberculous infection in adolescents and adults in a rural community in Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:218-22.
    PubMed     Text format     Abstract available


  278. KERKHOFF AD, Meintjes G, Opie J, Vogt M, et al
    Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency.
    Int J Tuberc Lung Dis. 2016;20:193-201.
    PubMed     Text format     Abstract available


  279. BONNET M, Bastard M, du Cros P, Khamraev A, et al
    Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Int J Tuberc Lung Dis. 2016;20:177-86.
    PubMed     Text format     Abstract available


  280. NIKAM C, Patel R, Sadani M, Ajbani K, et al
    Redefining MTBDRplus test results: what do indeterminate results actually mean?
    Int J Tuberc Lung Dis. 2016;20:154-9.
    PubMed     Text format     Abstract available


  281. GLAZIOU P, Floyd K, Weil D, Raviglione M, et al
    TB deaths rank alongside HIV deaths as top infectious killer.
    Int J Tuberc Lung Dis. 2016;20:143-4.
    PubMed     Text format    


    January 2016
  282. YANG PL, He XJ, Zang QJ, Li HP, et al
    Association of human leukocyte antigen DRB1 polymorphism and tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:121-8.
    PubMed     Text format     Abstract available


  283. WATANABE A, Matsumoto T, Igari H, Sawa J, et al
    Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan.
    Int J Tuberc Lung Dis. 2016;20:101-8.
    PubMed     Text format     Abstract available


  284. BURMEN B, Modi S, Cavanaugh JS, Muttai H, et al
    Tuberculosis screening outcomes for newly diagnosed persons living with HIV, Nyanza Province, Kenya, 2009.
    Int J Tuberc Lung Dis. 2016;20:79-84.
    PubMed     Text format     Abstract available


  285. AGUILERA XP, Gonzalez C, Najera-De Ferrari M, Hirmas M, et al
    Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection.
    Int J Tuberc Lung Dis. 2016;20:63-70.
    PubMed     Text format     Abstract available


  286. CHEN KS, Liu T, Lin RR, Peng YP, et al
    Tuberculosis transmission and risk factors in a Chinese antimony mining community.
    Int J Tuberc Lung Dis. 2016;20:57-62.
    PubMed     Text format     Abstract available


  287. KIM L, Moonan PK, Heilig CM, Woodruff RS, et al
    Factors associated with recurrent tuberculosis more than 12 months after treatment completion.
    Int J Tuberc Lung Dis. 2016;20:49-56.
    PubMed     Text format     Abstract available


  288. SHULDINER J, Leventhal A, Chemtob D, Mor Z, et al
    Mortality after anti-tuberculosis treatment completion: results of long-term follow-up.
    Int J Tuberc Lung Dis. 2016;20:43-8.
    PubMed     Text format     Abstract available


  289. DOMINGUEZ J, Boettger EC, Cirillo D, Cobelens F, et al
    Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.
    Int J Tuberc Lung Dis. 2016;20:24-42.
    PubMed     Text format     Abstract available


  290. YATES TA, Tanser F, Abubakar I
    Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings.
    Int J Tuberc Lung Dis. 2016;20:5-10.
    PubMed     Text format     Abstract available


  291. SOTGIU G, Centis R, Migliori GB
    Tuberculosis management and determinants of recurrence.
    Int J Tuberc Lung Dis. 2016;20:3.
    PubMed     Text format    


  292. VAN DEN HOF S, Borgdorff MW
    Elevated mortality after successful tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:2.
    PubMed     Text format    


  293. KO Y, Lee HK, Lee YS, Kim MY, et al
    Accuracy of Xpert((R)) MTB/RIF assay compared with AdvanSure TB/NTM real-time PCR using bronchoscopy specimens.
    Int J Tuberc Lung Dis. 2016;20:115-20.
    PubMed     Text format     Abstract available


  294. BENERI CA, Aaron L, Kim S, Jean-Philippe P, et al
    Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.
    Int J Tuberc Lung Dis. 2016;20:93-100.
    PubMed     Text format     Abstract available


  295. KAPOOR S, Gupta A, Shah M
    Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
    Int J Tuberc Lung Dis. 2016;20:85-92.
    PubMed     Text format     Abstract available


  296. HENSEL RL, Kempker RR, Tapia J, Oladele A, et al
    Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.
    Int J Tuberc Lung Dis. 2016;20:71-8.
    PubMed     Text format     Abstract available


    December 2015
  297. MURRAY S, McKenna L, Pelfrene E, Botgros R, et al
    Accelerating clinical drug development for children with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:69-74.
    PubMed     Text format     Abstract available


  298. TANEJA R, Garcia-Prats AJ, Furin J, Maheshwari HK, et al
    Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:61-8.
    PubMed     Text format     Abstract available


  299. FURIN J, Mafukidze A, Brigden G, du Cros P, et al
    A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:55-60.
    PubMed     Text format     Abstract available


  300. BASSYOUNI H, Breugelmans JG, Surette M, Olesen O, et al
    Childhood tuberculosis: a unified response to a global problem.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:54.
    PubMed     Text format    


  301. CRUZ AT, Martinez BJ
    Childhood tuberculosis in the United States: shifting the focus to prevention.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:50-3.
    PubMed     Text format     Abstract available


  302. AMANULLAH F, Malik AA
    Unmasking childhood tuberculosis in Pakistan: efforts to improve detection and management.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:47-9.
    PubMed     Text format     Abstract available


  303. SWAMINATHAN S, Sachdeva KS
    Treatment of childhood tuberculosis in India.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:43-6.
    PubMed     Text format     Abstract available


  304. MALECHE-OBIMBO E, Wanjau W, Kathure I
    The journey to improve the prevention and management of childhood tuberculosis: the Kenyan experience.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:39-42.
    PubMed     Text format     Abstract available


  305. MALHOTRA S, Ursu I, Ghoneim R, Jodrey PP, et al
    From availability to uptake: planning for the introduction of new, child-friendly anti-tuberculosis formulations.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:32-8.
    PubMed     Text format     Abstract available


  306. USHERENKO I, Basu Roy U, Mazlish S, Liu S, et al
    Pediatric tuberculosis drug market: an insider perspective on challenges and solutions.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:23-31.
    PubMed     Text format     Abstract available


  307. SCOTT C, Gardiner E, de Lucia A
    The procurement landscape of pediatric tuberculosis treatment: a Global Drug Facility perspective.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:17-22.
    PubMed     Text format     Abstract available


  308. SEDDON JA, Jenkins HE, Liu L, Cohen T, et al
    Counting children with tuberculosis: why numbers matter.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:9-16.
    PubMed     Text format     Abstract available


  309. GRAHAM SM, Grzemska M, Gie RP
    The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:3-8.
    PubMed     Text format     Abstract available


  310. GOOSBY E
    Out of the shadows: shining a light on children with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:1-2.
    PubMed     Text format    


  311. LAWN SD, Kerkhoff AD
    Rapid diagnosis of TB in HIV-positive in-patients with M. tuberculosis bacteraemia in sub-Saharan Africa.
    Int J Tuberc Lung Dis. 2015;19:1557-9.
    PubMed     Text format    


  312. O'CONNOR BD, Woltmann G, Patel H, Turapov O, et al
    Can resuscitation-promoting factors be used to improve culture rates of extra-pulmonary tuberculosis?
    Int J Tuberc Lung Dis. 2015;19:1556-7.
    PubMed     Text format    


  313. REINA S, Silva C, Gaio AR, Correia AM, et al
    HIV screening in tuberculosis patients in the northern region of Portugal.
    Int J Tuberc Lung Dis. 2015;19:1554-5.
    PubMed     Text format    


  314. ARDIZZONI E, Mulders W, Kotrikadze T, Aspindzelashvili R, et al
    The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1547-52.
    PubMed     Text format     Abstract available


  315. CAUSSE M, Ruiz P, Gutierrez JB, Vaquero M, et al
    New Anyplex II MTB/MDR/XDR kit for detection of resistance mutations in M. tuberculosis cultures.
    Int J Tuberc Lung Dis. 2015;19:1542-6.
    PubMed     Text format     Abstract available


  316. MALHOTRA B, Goyal S, Bhargava S, Reddy PV, et al
    Rapid detection of rifampicin resistance in Mycobacterium tuberculosis by high-resolution melting curve analysis.
    Int J Tuberc Lung Dis. 2015;19:1536-41.
    PubMed     Text format     Abstract available


  317. LORENT N, Kong C, Kim T, Sam S, et al
    Systematic screening for drug-resistant tuberculosis with Xpert((R)) MTB/RIF in a referral hospital in Cambodia.
    Int J Tuberc Lung Dis. 2015;19:1528-35.
    PubMed     Text format     Abstract available


  318. GUNTHER G, van Leth F, Altet N, Dedicoat M, et al
    Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
    Int J Tuberc Lung Dis. 2015;19:1524-7.
    PubMed     Text format     Abstract available


  319. CRUDU V, Merker M, Lange C, Noroc E, et al
    Nosocomial transmission of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1520-3.
    PubMed     Text format     Abstract available


  320. RAMMA L, Cox H, Wilkinson L, Foster N, et al
    Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa.
    Int J Tuberc Lung Dis. 2015;19:1513-9.
    PubMed     Text format     Abstract available


  321. MORENO-MARTINEZ A, Casals M, Orcau A, Gorrindo P, et al
    Factors associated with diabetes mellitus among adults with tuberculosis in a large European city, 2000-2013.
    Int J Tuberc Lung Dis. 2015;19:1507-12.
    PubMed     Text format     Abstract available


  322. LU MC, Lai CL, Tsai CC, Koo M, et al
    Increased risk of pulmonary and extra-pulmonary tuberculosis in patients with rheumatic diseases.
    Int J Tuberc Lung Dis. 2015;19:1500-6.
    PubMed     Text format     Abstract available


  323. AL-EFRAIJ K, Mota L, Lunny C, Schachter M, et al
    Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:1493-9.
    PubMed     Text format     Abstract available


  324. PAGAOA MA, Royce RA, Chen MP, Golub JE, et al
    Risk factors for transmission of tuberculosis among United States-born African Americans and Whites.
    Int J Tuberc Lung Dis. 2015;19:1485-92.
    PubMed     Text format     Abstract available


  325. CHUNG W, Lee K, Jung Y, Kim Y, et al
    Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1476-84.
    PubMed     Text format     Abstract available


  326. AMANATIDOU V, Critselis E, Trochoutsou A, Soldatou A, et al
    Interferon gamma inducible protein-10 in the diagnosis of paediatric tuberculosis infection in a low TB incidence country.
    Int J Tuberc Lung Dis. 2015;19:1463-9.
    PubMed     Text format     Abstract available


  327. LU TT, Lin XQ, Zhang L, Cai W, et al
    Magnetic resonance angiography manifestations and prognostic significance in HIV-negative tuberculosis meningitis.
    Int J Tuberc Lung Dis. 2015;19:1448-54.
    PubMed     Text format     Abstract available


  328. WANG Y, Wu JP, Qin GC, Li DY, et al
    Computerised tomography and intravenous pyelography in urinary tuberculosis: a retrospective descriptive study.
    Int J Tuberc Lung Dis. 2015;19:1441-7.
    PubMed     Text format     Abstract available


  329. ALLWOOD BW, Goldin J, Said-Hartley Q, van Zyl-Smit RN, et al
    Assessment of previous tuberculosis status using questionnaires, chest X-rays and computed tomography scans.
    Int J Tuberc Lung Dis. 2015;19:1435-40.
    PubMed     Text format     Abstract available


  330. TRIASIH R, Robertson C, de Campo J, Duke T, et al
    An evaluation of chest X-ray in the context of community-based screening of child tuberculosis contacts.
    Int J Tuberc Lung Dis. 2015;19:1428-34.
    PubMed     Text format     Abstract available


  331. CHANG KC, Yew WW, Sotgiu G
    Clinical research in the treatment of tuberculosis: current status and future prospects.
    Int J Tuberc Lung Dis. 2015;19:1417-27.
    PubMed     Text format     Abstract available


  332. COURTENAY-QUIRK C, Date A, Bachanas P, Baggaley R, et al
    Expanding human immunodeficiency virus testing and counseling to reach tuberculosis clients' partners and families.
    Int J Tuberc Lung Dis. 2015;19:1414-6.
    PubMed     Text format     Abstract available


  333. STOUT JE
    The cost of 'free' tuberculosis care.
    Int J Tuberc Lung Dis. 2015;19:1413.
    PubMed     Text format    


  334. OHKADO A
    How can we sensibly rule out previous episodes of pulmonary tuberculosis disease?
    Int J Tuberc Lung Dis. 2015;19:1412.
    PubMed     Text format    


    November 2015
  335. ABBARA A, Newsholme W, Klein JL, Chambers JB, et al
    Tuberculous endocarditis in an immunocompetent host without miliary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1407-8.
    PubMed     Text format    


  336. SHEN TC, Lin CL, Wei CC, Chen CH, et al
    Previous history of tuberculosis is associated with rheumatoid arthritis.
    Int J Tuberc Lung Dis. 2015;19:1401-5.
    PubMed     Text format     Abstract available


  337. YU SN, Cho OH, Park KH, Jung J, et al
    Late paradoxical lymph node enlargement during and after anti-tuberculosis treatment in non-HIV-infected patients.
    Int J Tuberc Lung Dis. 2015;19:1388-94.
    PubMed     Text format     Abstract available


  338. MANIKA K, Chatzika K, Papaioannou M, Kontou P, et al
    Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.
    Int J Tuberc Lung Dis. 2015;19:1383-7.
    PubMed     Text format     Abstract available


  339. HATSUDA K, Takeuchi M, Ogata K, Sasaki Y, et al
    The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1369-75.
    PubMed     Text format     Abstract available


  340. KRIEL M, Lotz JW, Kidd M, Walzl G, et al
    Evaluation of a radiological severity score to predict treatment outcome in adults with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1354-60.
    PubMed     Text format     Abstract available


  341. SHARMA A, Musau S, Heilig CM, Okumu AO, et al
    Assessing the effect of decentralisation of laboratory diagnosis for drug-resistant tuberculosis in Kenya.
    Int J Tuberc Lung Dis. 2015;19:1348-53.
    PubMed     Text format     Abstract available


  342. MARANGU D, Devine B, John-Stewart G
    Diagnostic accuracy of nucleic acid amplification tests in urine for pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:1339-47.
    PubMed     Text format     Abstract available


  343. COLVIN CJ, Leon N, Wills C, van Niekerk M, et al
    Global-to-local policy transfer in the introduction of new molecular tuberculosis diagnostics in South Africa.
    Int J Tuberc Lung Dis. 2015;19:1326-38.
    PubMed     Text format     Abstract available


  344. DOS SANTOS DIAS E, do Prado TN, da Silva Guimaraes AL, Ramos MC, et al
    Childhood tuberculosis and human immunodeficiency virus status in Brazil: a hierarchical analysis.
    Int J Tuberc Lung Dis. 2015;19:1305-11.
    PubMed     Text format     Abstract available


  345. KAWATSU L, Izumi K, Uchimura K, Urakawa M, et al
    Can social network analysis assist in the prioritisation of contacts in a tuberculosis contact investigation?
    Int J Tuberc Lung Dis. 2015;19:1293-9.
    PubMed     Text format     Abstract available


  346. ZHANG Y, Yew WW
    Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.
    Int J Tuberc Lung Dis. 2015;19:1276-89.
    PubMed     Text format     Abstract available


  347. ZACHARIAH R, Ortuno N, Hermans V, Desalegn W, et al
    Ebola, fragile health systems and tuberculosis care: a call for pre-emptive action and operational research.
    Int J Tuberc Lung Dis. 2015;19:1271-5.
    PubMed     Text format     Abstract available


  348. SLOAN DJ, O'Dempsey TJ
    Tuberculosis in the time of Ebola: obstacles and opportunities.
    Int J Tuberc Lung Dis. 2015;19:1269.
    PubMed     Text format    


  349. TREBUCQ A, Devi S
    Widespread use of Xpert((R)) MTB/RIF will most probably reduce the total number of TB cases notified.
    Int J Tuberc Lung Dis. 2015;19:1406.
    PubMed     Text format    


  350. CRESWELL J, Rai B, Codlin AJ
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1406-7.
    PubMed     Text format    


    October 2015
  351. VOLZ MS, Loddenkemper C, Morguet A, Moos V, et al
    Cardiac myxoma secreting interleukin-6 promotes cavitary tuberculosis: a case report.
    Int J Tuberc Lung Dis. 2015;19:1265-6.
    PubMed     Text format    


  352. NUNN AJ, Phillips PP, Abubakar I
    Reducing relapse in tuberculosis treatment.
    Int J Tuberc Lung Dis. 2015;19:1263-4.
    PubMed     Text format    


  353. GUPTA R, Geiter LJ, Hafkin J, Wells CD, et al
    Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1261-2.
    PubMed     Text format    


  354. PAINTER JA, Posey DL, Phares C
    Tuberculosis misclassification among immigrants.
    Int J Tuberc Lung Dis. 2015;19:1259-60.
    PubMed     Text format    


  355. DENHOLM JT, Matteelli A, Reis A
    In reply. Promoting ethical and evidence-based policies for latent tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1258-9.
    PubMed     Text format    


  356. LI N, Xie WP, Kong H, Min R, et al
    Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1230-8.
    PubMed     Text format     Abstract available


  357. KAMBLI P, Ajbani K, Nikam C, Khillari A, et al
    Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.
    Int J Tuberc Lung Dis. 2015;19:1227-9.
    PubMed     Text format     Abstract available


  358. ELMARAACHLI W, Slater M, Berrada ZL, Lin SY, et al
    Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
    Int J Tuberc Lung Dis. 2015;19:1222-6.
    PubMed     Text format     Abstract available


  359. KIM YW, Seong MW, Kim TS, Yoo CG, et al
    Evaluation of Xpert((R)) MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1216-21.
    PubMed     Text format     Abstract available


  360. TU HZ, Lin YE, Tseng MR, Huang TS, et al
    Cost-effective identification of Mycobacterium tuberculosis complex using microscopic morphology and rapid tests.
    Int J Tuberc Lung Dis. 2015;19:1204-8.
    PubMed     Text format     Abstract available


  361. ADELMAN MW, Tsegaye M, Kempker RR, Alebachew T, et al
    Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2015;19:1197-203.
    PubMed     Text format     Abstract available


  362. REIS-SANTOS B, Pellacani-Posses I, Macedo LR, Golub JE, et al
    Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.
    Int J Tuberc Lung Dis. 2015;19:1188-93.
    PubMed     Text format     Abstract available


  363. VALENCA MS, Scaini JL, Abileira FS, Goncalves CV, et al
    Prevalence of tuberculosis in prisons: risk factors and molecular epidemiology.
    Int J Tuberc Lung Dis. 2015;19:1182-7.
    PubMed     Text format     Abstract available


  364. KOSGEI RJ, Sitienei JK, Kipruto H, Kimenye K, et al
    Gender differences in treatment outcomes among 15-49 year olds with smear-positive pulmonary tuberculosis in Kenya.
    Int J Tuberc Lung Dis. 2015;19:1176-81.
    PubMed     Text format     Abstract available


  365. KAMPER-JORGENSEN Z, Carstensen B, Norredam M, Bygbjerg IC, et al
    Diabetes-related tuberculosis in Denmark: effect of ethnicity, diabetes duration and year of diagnosis.
    Int J Tuberc Lung Dis. 2015;19:1169-75.
    PubMed     Text format     Abstract available


  366. SHIDAM UG, Roy G, Sahu SK, Kumar SV, et al
    Screening for diabetes among presumptive tuberculosis patients at a tertiary care centre in Pondicherry, India.
    Int J Tuberc Lung Dis. 2015;19:1163-8.
    PubMed     Text format     Abstract available


  367. MUKHERJEE A, Khandelwal D, Singla M, Lodha R, et al
    Outcomes of Category II anti-tuberculosis treatment in Indian children.
    Int J Tuberc Lung Dis. 2015;19:1153-7.
    PubMed     Text format     Abstract available


  368. CHIANG SS, Roche S, Contreras C, Alarcon V, et al
    Barriers to the diagnosis of childhood tuberculosis: a qualitative study.
    Int J Tuberc Lung Dis. 2015;19:1144-52.
    PubMed     Text format     Abstract available


  369. MASON PH, Degeling C, Denholm J
    Sociocultural dimensions of tuberculosis: an overview of key concepts.
    Int J Tuberc Lung Dis. 2015;19:1135-43.
    PubMed     Text format     Abstract available


  370. SOTGIU G, Matteelli A, Migliori GB
    Diabetes and tuberculosis: what else beyond?
    Int J Tuberc Lung Dis. 2015;19:1127-8.
    PubMed     Text format    


  371. STEVENSON DR, Biswas JR, Lievesley A, Quinn G, et al
    False-positive Xpert((R)) MTB/RIF more than seven years after cure.
    Int J Tuberc Lung Dis. 2015;19:1264-5.
    PubMed     Text format    


  372. EVANS TB, Mador MJ, Glick M
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1260-1.
    PubMed     Text format    


  373. NOESKE J
    Sovereignty or dignity?
    Int J Tuberc Lung Dis. 2015;19:1258.
    PubMed     Text format    


  374. FURIN J, Harausz E, Zimetbaum P, Cox H, et al
    In reply. QTc prolongation and delamanid: access and safety.
    Int J Tuberc Lung Dis. 2015;19:1262-3.
    PubMed     Text format    


  375. JOHNSTON JC, Khan FA, Dowdy DW
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1264.
    PubMed     Text format    


    September 2015
  376. ATRE S
    Notification of multidrug-resistant tuberculosis cases and treatment outcomes in the private sector.
    Int J Tuberc Lung Dis. 2015;19:1126.
    PubMed     Text format    


  377. RATNAPPULI A, Collinson S, Gaspar-Garcia E, Richardson L, et al
    Pott's disease in twenty-first century London: spinal tuberculosis as a continuing cause of morbidity and mortality.
    Int J Tuberc Lung Dis. 2015;19:1125-6.
    PubMed     Text format    


  378. SUEN SC, Bendavid E, Goldhaber-Fiebert JD
    Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India.
    Int J Tuberc Lung Dis. 2015;19:1115-24.
    PubMed     Text format     Abstract available


  379. CHOI Y, Hong SR, Jeon BY, Wang HY, et al
    Conventional and real-time PCR targeting 16S ribosomal RNA for the detection of Mycobacterium tuberculosis complex.
    Int J Tuberc Lung Dis. 2015;19:1102-8.
    PubMed     Text format     Abstract available


  380. HEO EY, Choi NK, Yang BR, Koo BK, et al
    Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus.
    Int J Tuberc Lung Dis. 2015;19:1098-101.
    PubMed     Text format     Abstract available


  381. TOGUN TO, Egere U, Sillah AK, Ayorinde A, et al
    Contribution of Xpert((R)) MTB/RIF to the diagnosis of pulmonary tuberculosis among TB-exposed children in The Gambia.
    Int J Tuberc Lung Dis. 2015;19:1091-7.
    PubMed     Text format     Abstract available


  382. PAGE AL, Ardizzoni E, Lassovsky M, Kirubi B, et al
    Routine use of Xpert((R)) MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1078-83.
    PubMed     Text format     Abstract available


  383. BASU I, Bower JE, Henderson GK, Lowe O, et al
    False-negative BD MGIT TBc Identification Test results in routine tuberculosis diagnosis: a New Zealand perspective.
    Int J Tuberc Lung Dis. 2015;19:1073-5.
    PubMed     Text format     Abstract available


  384. HERNANDEZ P, Punchak M, Camacho M, Hepple P, et al
    Investigating the quality of expectorated sputum for tuberculosis diagnosis in Bolivia.
    Int J Tuberc Lung Dis. 2015;19:1065-7.
    PubMed     Text format     Abstract available


  385. GARFEIN RS, Collins K, Munoz F, Moser K, et al
    Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study.
    Int J Tuberc Lung Dis. 2015;19:1057-64.
    PubMed     Text format     Abstract available


  386. SITIENEI J, Kipruto H, Mansour O, Ndisha M, et al
    Correlates of default from anti-tuberculosis treatment: a case study using Kenya's electronic data system.
    Int J Tuberc Lung Dis. 2015;19:1051-6.
    PubMed     Text format     Abstract available


  387. SALYER SJ, Fitter DL, Milo R, Blanton C, et al
    Evaluation of the national tuberculosis surveillance program in Haiti.
    Int J Tuberc Lung Dis. 2015;19:1045-50.
    PubMed     Text format     Abstract available


  388. MORALES-GARCIA C, Parra-Ruiz J, Sanchez-Martinez JA, Delgado-Martin AE, et al
    Concomitant tuberculosis and lung cancer diagnosed by bronchoscopy.
    Int J Tuberc Lung Dis. 2015;19:1027-32.
    PubMed     Text format     Abstract available


  389. DEDICOAT M, Lange C
    Tuberculosis preventive chemotherapy: the times they are a-changin'.
    Int J Tuberc Lung Dis. 2015;19:1002.
    PubMed     Text format    


    August 2015
  390. REMASCHI G, Venturini E, Romano F, Perrone A, et al
    A rare cause of osteomyelitis with a rare genetic mutation: when Mycobacterium doesn't only mean tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:999-1000.
    PubMed     Text format    


  391. JOON D, Nimesh M, Saluja D
    Loop-mediated isothermal amplification as alternative to PCR for the diagnosis of extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:986-91.
    PubMed     Text format     Abstract available


  392. NDJEKA N, Conradie F, Schnippel K, Hughes J, et al
    Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.
    Int J Tuberc Lung Dis. 2015;19:979-85.
    PubMed     Text format     Abstract available


  393. DU TOIT E, Squire SB, Dunbar R, Machekano R, et al
    Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa.
    Int J Tuberc Lung Dis. 2015;19:960-8.
    PubMed     Text format     Abstract available


  394. ASANTE-POKU A, Otchere ID, Danso E, Mensah DD, et al
    Evaluation of GenoType((R)) MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.
    Int J Tuberc Lung Dis. 2015;19:954-9.
    PubMed     Text format     Abstract available


  395. HIRSCH-MOVERMAN Y, Cronin WA, Chen B, Moran JA, et al
    HIV counseling and testing in tuberculosis contact investigations in the United States and Canada.
    Int J Tuberc Lung Dis. 2015;19:943-53.
    PubMed     Text format     Abstract available


  396. LAI CC, Lee MT, Lee SH, Lee SH, et al
    Risk of incident active tuberculosis and use of corticosteroids.
    Int J Tuberc Lung Dis. 2015;19:936-42.
    PubMed     Text format     Abstract available


  397. KAWATSU L, Uchimura K, Kobayashi M, Ishikawa N, et al
    Overview of the tuberculosis burden in prison institutions in Japan, 2000-2012.
    Int J Tuberc Lung Dis. 2015;19:921-6.
    PubMed     Text format     Abstract available


  398. IWATA K, Doi A, Nakamura T, Yoshida H, et al
    The validity of three sputum smears taken in one day for discontinuing isolation of tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:918-20.
    PubMed     Text format     Abstract available


  399. SHETE PB, Haguma P, Miller CR, Ochom E, et al
    Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda.
    Int J Tuberc Lung Dis. 2015;19:912-7.
    PubMed     Text format     Abstract available


  400. SLOAN DJ, Mwandumba HC, Kamdolozi M, Shani D, et al
    Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes.
    Int J Tuberc Lung Dis. 2015;19:904-11.
    PubMed     Text format     Abstract available


  401. JERENE D, Melese M, Kassie Y, Alem G, et al
    The yield of a tuberculosis household contact investigation in two regions of Ethiopia.
    Int J Tuberc Lung Dis. 2015;19:898-903.
    PubMed     Text format     Abstract available


  402. HARRIES AD, Kumar AM, Satyanarayana S, Lin Y, et al
    Diabetes mellitus and tuberculosis: programmatic management issues.
    Int J Tuberc Lung Dis. 2015;19:879-86.
    PubMed     Text format     Abstract available


  403. DAVIES PD, Martineau AR
    Vitamin D and tuberculosis: more effective in prevention than treatment?
    Int J Tuberc Lung Dis. 2015;19:876-7.
    PubMed     Text format    


  404. DAVIES PD
    Towards the elimination of tuberculosis and a reduction in chest diseases.
    Int J Tuberc Lung Dis. 2015;19:875.
    PubMed     Text format    


    July 2015
  405. VOLZ MS, Epple HJ, Schneider T
    Immune reconstitution inflammatory syndrome after BCG infection mimicking miliary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:873-4.
    PubMed     Text format    


  406. BALAJEE KL, Rizwan SA, Kulkarni V, Silan V, et al
    Fixed-dose combination drugs for the treatment of tuberculosis under India's RNTCP.
    Int J Tuberc Lung Dis. 2015;19:870-1.
    PubMed     Text format    


  407. KOWADA A
    Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
    Int J Tuberc Lung Dis. 2015;19:857-63.
    PubMed     Text format     Abstract available


  408. ROBERTS-WITTEVEEN A, Reinten T, Christensen A, Sintchenko V, et al
    Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
    Int J Tuberc Lung Dis. 2015;19:850-6.
    PubMed     Text format     Abstract available


  409. LI CP, Zhou Y, Xiang X, Zhou Y, et al
    Relationship of HLA-DRB1 gene polymorphism with susceptibility to pulmonary tuberculosis: updated meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:841-9.
    PubMed     Text format     Abstract available


  410. KAMUDUMULI PS, Beylis N, Blann L, Duse A, et al
    Molecular typing of drug-susceptible and -resistant Mycobacterium tuberculosis in Johannesburg, South Africa.
    Int J Tuberc Lung Dis. 2015;19:834-40.
    PubMed     Text format     Abstract available


  411. JUBULIS J, Dionne K, Osterhout G, Ayuk L, et al
    Mycobacterium tuberculosis resistance in pulmonary TB patients in Cameroon: a phenotypic susceptibility assay.
    Int J Tuberc Lung Dis. 2015;19:823-7.
    PubMed     Text format     Abstract available


  412. RIENTHONG S, Boonin C, Chaiyasirinrote B, Satproedprai N, et al
    Evaluation of a novel line-probe assay for genotyping-based diagnosis of Mycobacterium tuberculosis in Thailand.
    Int J Tuberc Lung Dis. 2015;19:817-22.
    PubMed     Text format     Abstract available


  413. DE LA MORA IL, Martinez-Oceguera D, Laniado-Laborin R
    Chronic airway obstruction after successful treatment of tuberculosis and its impact on quality of life.
    Int J Tuberc Lung Dis. 2015;19:808-10.
    PubMed     Text format     Abstract available


  414. HEMANTH KUMAR AK, Narendran G, Kumar RS, Ramachandran G, et al
    RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2015;19:805-7.
    PubMed     Text format     Abstract available


  415. JONNALAGADDA S, LaCourse SM, Otieno P, Lohman-Payne B, et al
    Incidence and correlates of tuberculosis IGRA conversion among HIV-infected postpartum women.
    Int J Tuberc Lung Dis. 2015;19:792-8.
    PubMed     Text format     Abstract available


  416. ZHANG XL, Li SG, Li HT, Li GX, et al
    Integrating tuberculosis screening into annual health examinations for the rural elderly improves case detection.
    Int J Tuberc Lung Dis. 2015;19:787-91.
    PubMed     Text format     Abstract available


  417. DAWSON R, Narunsky K, Carman D, Gupte N, et al
    Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:780-6.
    PubMed     Text format     Abstract available


  418. GAO Z, Parhar A, Gallant V, Heffernan C, et al
    A population-based study of tuberculosis case fatality in Canada: do Aboriginal peoples fare less well?
    Int J Tuberc Lung Dis. 2015;19:772-9.
    PubMed     Text format     Abstract available


  419. LIEW SM, Khoo EM, Ho BK, Lee YK, et al
    Tuberculosis in Malaysia: predictors of treatment outcomes in a national registry.
    Int J Tuberc Lung Dis. 2015;19:764-71.
    PubMed     Text format     Abstract available


  420. SATYANARAYANA S, Subbaraman R, Shete P, Gore G, et al
    Quality of tuberculosis care in India: a systematic review.
    Int J Tuberc Lung Dis. 2015;19:751-63.
    PubMed     Text format     Abstract available


  421. ADAMS CD, Velez JD, Martinez LF
    Xpert((R)) MTB/RIF and very low positive detection in bronchoalveolar lavage: diagnostic concerns.
    Int J Tuberc Lung Dis. 2015;19:871-3.
    PubMed     Text format    


  422. SIMONS SO, van der Laan T, de Zwaan R, Kamst M, et al
    Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.
    Int J Tuberc Lung Dis. 2015;19:828-33.
    PubMed     Text format     Abstract available


  423. HANRAHAN CF, Clouse K, Bassett J, Mutunga L, et al
    The patient impact of point-of-care vs. laboratory placement of Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2015;19:811-6.
    PubMed     Text format     Abstract available


  424. BISHARA H, Ore L, Vinitsky O, Bshara H, et al
    Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel.
    Int J Tuberc Lung Dis. 2015;19:799-804.
    PubMed     Text format     Abstract available


    June 2015
  425. PADBERG I, Batzing-Feigenbaum J, Sagebiel D
    Association of extra-pulmonary tuberculosis with age, sex and season differs depending on the affected organ.
    Int J Tuberc Lung Dis. 2015;19:723-8.
    PubMed     Text format     Abstract available


  426. CHEN LM, Liu YQ, Shen JN, Peng YL, et al
    The 100 top-cited tuberculosis research studies.
    Int J Tuberc Lung Dis. 2015;19:717-22.
    PubMed     Text format     Abstract available


  427. O'HARA GA, Abdullah S, Creer DD, Elsaghier AF, et al
    Cord formation in BACTEC(TM) medium aids rapid identification of Mycobacterium tuberculosis complex.
    Int J Tuberc Lung Dis. 2015;19:709-10.
    PubMed     Text format     Abstract available


  428. OH JY, Sim JK, Jung WJ, Min KH, et al
    Association between interleukin-27 polymorphisms and pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:702-8.
    PubMed     Text format     Abstract available


  429. KELLY V, Sagili KD, Satyanarayana S, Reza LW, et al
    Cost-utility analysis of LED fluorescence microscopy in the diagnosis of pulmonary tuberculosis in Indian settings.
    Int J Tuberc Lung Dis. 2015;19:696-701.
    PubMed     Text format     Abstract available


  430. MUSAU S, McCarthy K, Okumu A, Shinnick T, et al
    Experience in implementing a quality management system in a tuberculosis laboratory, Kisumu, Kenya.
    Int J Tuberc Lung Dis. 2015;19:693-5.
    PubMed     Text format     Abstract available


  431. MAGEE MJ, Kempker RR, Kipiani M, Gandhi NR, et al
    Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
    Int J Tuberc Lung Dis. 2015;19:685-92.
    PubMed     Text format     Abstract available


  432. ALAME-EMANE AK, Xu P, Pierre-Audigier C, Cadet-Daniel V, et al
    Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
    Int J Tuberc Lung Dis. 2015;19:679-84.
    PubMed     Text format     Abstract available


  433. NHUNG NV, Hoa NB, Sy DN, Hennig CM, et al
    The fourth national anti-tuberculosis drug resistance survey in viet nam.
    Int J Tuberc Lung Dis. 2015;19:670-5.
    PubMed     Text format     Abstract available


  434. MOORE BK, Anyalechi E, van der Walt M, Smith S, et al
    Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010.
    Int J Tuberc Lung Dis. 2015;19:663-9.
    PubMed     Text format     Abstract available


  435. DOBLER CC, Korver S, Batbayar O, Oyuntsetseg S, et al
    Success of community-based directly observed anti-tuberculosis treatment in Mongolia.
    Int J Tuberc Lung Dis. 2015;19:657-62.
    PubMed     Text format     Abstract available


  436. FATIMA R, Qadeer E, Hinderaker SG, Yaqoob A, et al
    Can the number of patients with presumptive tuberculosis lost in the general health services in Pakistan be reduced?
    Int J Tuberc Lung Dis. 2015;19:654-6.
    PubMed     Text format     Abstract available


  437. SENKORO M, Hinderaker SG, Mfinanga SG, Range N, et al
    Health care-seeking behaviour among people with cough in Tanzania: findings from a tuberculosis prevalence survey.
    Int J Tuberc Lung Dis. 2015;19:640-6.
    PubMed     Text format     Abstract available


  438. SUBRAMANI R, Kolappan C, Chandrasekaran V, Selvakumar N, et al
    Could repeated prevalence surveys lead to decreasing tuberculosis prevalence in a community?
    Int J Tuberc Lung Dis. 2015;19:635-9.
    PubMed     Text format     Abstract available


  439. DAVIES GR, Phillips PP, Jaki T
    Adaptive clinical trials in tuberculosis: applications, challenges and solutions.
    Int J Tuberc Lung Dis. 2015;19:626-34.
    PubMed     Text format     Abstract available


  440. SEDDON JA
    Time to be a bit more 'surgical' in our management of children with drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:625.
    PubMed     Text format    


  441. JOHNSTON JC, Khan FA, Dowdy DW
    Reducing relapse in tuberculosis treatment: is it time to reassess WHO treatment guidelines?
    Int J Tuberc Lung Dis. 2015;19:624.
    PubMed     Text format    


  442. GETAHUN H, Varma J
    Transitioning from 'stopping' to 'ending' the tuberculosis epidemic.
    Int J Tuberc Lung Dis. 2015;19:623-4.
    PubMed     Text format    


  443. BABLISHVILI N, Tukvadze N, Avaliani Z, Blumberg HM, et al
    A comparison of the Xpert((R)) MTB/RIF and GenoType((R)) MTBDRplus assays in Georgia.
    Int J Tuberc Lung Dis. 2015;19:676-8.
    PubMed     Text format     Abstract available


  444. MCCARTHY KM, Scott LE, Gous N, Tellie M, et al
    High incidence of latent tuberculous infection among South African health workers: an urgent call for action.
    Int J Tuberc Lung Dis. 2015;19:647-53.
    PubMed     Text format     Abstract available


    May 2015
  445. NAIK BR, Shastri SG, Vishwanath NS, Suryakanth MD, et al
    Adverse drug reactions in tuberculosis patients: consequences for TB control.
    Int J Tuberc Lung Dis. 2015;19:621-2.
    PubMed     Text format    


  446. JAFTA N, Jeena PM, Barregard L, Naidoo RN, et al
    Childhood tuberculosis and exposure to indoor air pollution: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:596-602.
    PubMed     Text format     Abstract available


  447. KO Y, Lee YM, Lee HY, Lee YS, et al
    Changes in lung function according to disease extent before and after pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:589-95.
    PubMed     Text format     Abstract available


  448. CHOI JC, Jarlsberg LG, Grinsdale JA, Osmond DH, et al
    Reduced sensitivity of the QuantiFERON((R)) test in diabetic patients with smear-negative tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:582-8.
    PubMed     Text format     Abstract available


  449. KIM HJ, Lee GH, Ryoo S, Oh SY, et al
    Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea.
    Int J Tuberc Lung Dis. 2015;19:576-81.
    PubMed     Text format     Abstract available


  450. ATWINE D, Nansumba M, Orikiriza P, Riera M, et al
    Intra-gastric string test: an effective tool for diagnosing tuberculosis in adults unable to produce sputum.
    Int J Tuberc Lung Dis. 2015;19:558-64.
    PubMed     Text format     Abstract available


  451. DAUM LT, Peters RP, Fourie PB, Jonkman K, et al
    Molecular detection of Mycobacterium tuberculosis from sputum transported in PrimeStore((R)) from rural settings.
    Int J Tuberc Lung Dis. 2015;19:552-7.
    PubMed     Text format     Abstract available


  452. CRESWELL J, Rai B, Wali R, Sudrungrot S, et al
    Introducing new tuberculosis diagnostics: the impact of Xpert((R)) MTB/RIF testing on case notifications in Nepal.
    Int J Tuberc Lung Dis. 2015;19:545-51.
    PubMed     Text format     Abstract available


  453. HO J, Marks GB, Fox GJ
    The impact of sputum quality on tuberculosis diagnosis: a systematic review.
    Int J Tuberc Lung Dis. 2015;19:537-44.
    PubMed     Text format     Abstract available


  454. DA S GARRIDO M, Buhrer-Sekula S, Souza AB, de Oliveira GP, et al
    Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011.
    Int J Tuberc Lung Dis. 2015;19:531-6.
    PubMed     Text format     Abstract available


  455. KWAK N, Kim HR, Yoo CG, Kim YW, et al
    Changes in treatment outcomes of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:525-30.
    PubMed     Text format     Abstract available


  456. DORMAN S
    Advances in the diagnosis of tuberculosis: current status and future prospects.
    Int J Tuberc Lung Dis. 2015;19:504-16.
    PubMed     Text format     Abstract available


  457. MURRAY JF
    The Industrial Revolution and the decline in death rates from tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:502-3.
    PubMed     Text format    


  458. NUERMBERGER E, Yew WW
    Expanding the evidence base supporting shorter treatment durations for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:497-8.
    PubMed     Text format    


  459. RASHID ALI MR, Parameswaran U, William T, Bird E, et al
    A prospective study of mycobacterial viability in refrigerated, unpreserved sputum batched for up to 8 weeks.
    Int J Tuberc Lung Dis. 2015;19:620-1.
    PubMed     Text format    


  460. MUNN MS, Duchin JS, Kay M, Pecha M, et al
    Analysis of risk factors for tuberculous infection following exposure at a homeless shelter.
    Int J Tuberc Lung Dis. 2015;19:570-5.
    PubMed     Text format     Abstract available


  461. SUBEDI P, Drezner KA, Dogbey MC, Newbern EC, et al
    Evaluation of latent tuberculous infection and treatment completion for refugees in Philadelphia, PA, 2010-2012.
    Int J Tuberc Lung Dis. 2015;19:565-9.
    PubMed     Text format     Abstract available


  462. KUABAN C, Noeske J, Rieder HL, Ait-Khaled N, et al
    High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
    Int J Tuberc Lung Dis. 2015;19:517-24.
    PubMed     Text format     Abstract available


  463. YEW WW, Chiang CY, Lumb R, Islam T, et al
    Are pulmonary non-tuberculous mycobacteria of concern in the Western Pacific Region?
    Int J Tuberc Lung Dis. 2015;19:499-500.
    PubMed     Text format    


    April 2015
  464. DUDNYK A, Rzhepishevska O, Rogach K, Kutsyna G, et al
    Multidrug-resistant tuberculosis in Ukraine at a time of military conflict.
    Int J Tuberc Lung Dis. 2015;19:492-3.
    PubMed     Text format    


  465. CHU NH, Li L, Zhang X, Gu J, et al
    Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease.
    Int J Tuberc Lung Dis. 2015;19:475-80.
    PubMed     Text format     Abstract available


  466. JAFARI-KOSHKI T, Arsang-Jang S, Raei M
    Applying spatiotemporal models to study risk of smear-positive tuberculosis in Iran, 2001-2012.
    Int J Tuberc Lung Dis. 2015;19:469-74.
    PubMed     Text format     Abstract available


  467. JOHN S, Gidado M, Dahiru T, Fanning A, et al
    Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding.
    Int J Tuberc Lung Dis. 2015;19:463-8.
    PubMed     Text format     Abstract available


  468. WISEMAN CA, Mandalakas AM, Kirchner HL, Gie RP, et al
    Novel application of NIH case definitions in a paediatric tuberculosis contact investigation study.
    Int J Tuberc Lung Dis. 2015;19:446-53.
    PubMed     Text format     Abstract available


  469. ARYA A, Roy V, Lomash A, Kapoor S, et al
    Rifampicin pharmacokinetics in children under the Revised National Tuberculosis Control Programme, India, 2009.
    Int J Tuberc Lung Dis. 2015;19:440-5.
    PubMed     Text format     Abstract available


  470. CHAIDIR L, Sengstake S, de Beer J, Krismawati H, et al
    Mycobacterium tuberculosis genotypic drug resistance patterns and clustering in Jayapura, Papua, Indonesia.
    Int J Tuberc Lung Dis. 2015;19:428-33.
    PubMed     Text format     Abstract available


  471. GARFEIN RS, Catanzaro DG, Rodwell TC, Avalos E, et al
    Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.
    Int J Tuberc Lung Dis. 2015;19:420-7.
    PubMed     Text format     Abstract available


  472. WEI XL, Yin J, Zou GY, Zhang ZT, et al
    Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China.
    Int J Tuberc Lung Dis. 2015;19:413-9.
    PubMed     Text format     Abstract available


  473. VAN ALTENA R, de Vries G, Haar CH, de Lange WC, et al
    Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    Int J Tuberc Lung Dis. 2015;19:406-12.
    PubMed     Text format     Abstract available


  474. GELMANOVA IY, Ahmad Khan F, Becerra MC, Zemlyanaya NA, et al
    Low rates of recurrence after successful treatment of multidrug-resistant tuberculosis in Tomsk, Russia.
    Int J Tuberc Lung Dis. 2015;19:399-405.
    PubMed     Text format     Abstract available


  475. HARAUSZ E, Cox H, Rich M, Mitnick CD, et al
    QTc prolongation and treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:385-91.
    PubMed     Text format     Abstract available


  476. BARRERA E, Livchits V, Nardell E
    F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy.
    Int J Tuberc Lung Dis. 2015;19:381-4.
    PubMed     Text format    


  477. ANDREWS JR, Basu S, Dowdy DW, Murray MB, et al
    The epidemiological advantage of preferential targeting of tuberculosis control at the poor.
    Int J Tuberc Lung Dis. 2015;19:375-80.
    PubMed     Text format     Abstract available


  478. DANIEL TM, Iversen PA
    Hippocrates and tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:373-4.
    PubMed     Text format    


  479. REVES RR
    In reply.
    Int J Tuberc Lung Dis. 2015;19:495.
    PubMed     Text format    


  480. BOYLES TH, Hughes J, Cox V, Burton R, et al
    False-positive Xpert((R)) MTB/RIF assays and previous treatment.
    Int J Tuberc Lung Dis. 2015;19:495-6.
    PubMed     Text format    


  481. PHILLIPS PP, Lipman MC
    Safe and effective treatment for patients with isoniazid drug resistance.
    Int J Tuberc Lung Dis. 2015;19:494-5.
    PubMed     Text format    


  482. ZELLWEGER JP, Bodmer T, Bischler U, Mykychak M, et al
    Implementation of the Stop TB strategy in a large TB hospital in Ukraine: achievements and deficiencies.
    Int J Tuberc Lung Dis. 2015;19:493-4.
    PubMed     Text format    


  483. HESSELING AC, Jaspan HB, Black GF, Nene N, et al
    Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.
    Int J Tuberc Lung Dis. 2015;19:454-62.
    PubMed     Text format     Abstract available


  484. KUMAR P, Kumar P, Balooni V, Singh S, et al
    Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
    Int J Tuberc Lung Dis. 2015;19:434-9.
    PubMed     Text format     Abstract available


  485. VAN DEN HANDEL T, Hampton KH, Sanne I, Stevens W, et al
    The impact of Xpert((R)) MTB/RIF in sparsely populated rural settings.
    Int J Tuberc Lung Dis. 2015;19:392-8.
    PubMed     Text format     Abstract available


  486. YIM JJ, Koh WJ
    MDR-TB recurrence after successful treatment: additional studies using molecular genotyping are needed.
    Int J Tuberc Lung Dis. 2015;19:371.
    PubMed     Text format    


    March 2015
  487. FLORES-SUAREZ LF, Saldarriaga Rivera LM, Rivera Rosales RM, Ruiz N, et al
    Cavitary tuberculosis and tracheal stenosis simulating granulomatosis with polyangiitis.
    Int J Tuberc Lung Dis. 2015;19:369-70.
    PubMed     Text format    


  488. VERMA S, Verma G, Singh DV, Mokta J, et al
    Dual infection with pulmonary tuberculosis and Lophomonas blattarum in India.
    Int J Tuberc Lung Dis. 2015;19:368-9.
    PubMed     Text format    


  489. LALLI M, Houben R, Churchyard G, White RG, et al
    Regarding the effect of cured tuberculosis disease on longevity.
    Int J Tuberc Lung Dis. 2015;19:367.
    PubMed     Text format    


  490. FARHAT MR, Mitnick CD, Franke MF, Kaur D, et al
    Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment.
    Int J Tuberc Lung Dis. 2015;19:339-41.
    PubMed     Text format     Abstract available


  491. RICKS PM, Hershow RC, Rahimian A, Huo D, et al
    A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:326-32.
    PubMed     Text format     Abstract available


  492. HUANG FL, Jin JL, Chen S, Zhou Z, et al
    MTBDRplus results correlate with treatment outcome in previously treated tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:319-25.
    PubMed     Text format     Abstract available


  493. UCHIMURA K, Ngamvithayapong-Yanai J, Kawatsu L, Ohkado A, et al
    Permanent employment or public assistance may increase tuberculosis survival among working-age patients in Japan.
    Int J Tuberc Lung Dis. 2015;19:312-8.
    PubMed     Text format     Abstract available


  494. HSIA NY, Ho YH, Shen TC, Lin CL, et al
    Risk of cataract for people with tuberculosis: results from a population-based cohort study.
    Int J Tuberc Lung Dis. 2015;19:305-11.
    PubMed     Text format     Abstract available


  495. MAVE V, Chandanwale A, Bhosale R, Shere D, et al
    Vitamin D deficiency and risk of postpartum tuberculosis among HIV-infected breastfeeding mothers in India.
    Int J Tuberc Lung Dis. 2015;19:302-4.
    PubMed     Text format     Abstract available


  496. UKWAJA KN, Oshi SN, Alobu I, Oshi DC, et al
    Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
    Int J Tuberc Lung Dis. 2015;19:295-301.
    PubMed     Text format     Abstract available


  497. AVILOV KK, Romanyukha AA, Borisov SE, Belilovsky EM, et al
    An approach to estimating tuberculosis incidence and case detection rate from routine notification data.
    Int J Tuberc Lung Dis. 2015;19:288-94.
    PubMed     Text format     Abstract available


  498. PENZ E, Boffa J, Roberts DJ, Fisher D, et al
    Diagnostic accuracy of the Xpert((R)) MTB/RIF assay for extra-pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:278-84.
    PubMed     Text format     Abstract available


  499. FAIR E, Miller CR, Ottmani SE, Fox GJ, et al
    Tuberculosis contact investigation in low- and middle-income countries: standardized definitions and indicators.
    Int J Tuberc Lung Dis. 2015;19:269-72.
    PubMed     Text format     Abstract available


  500. DANIEL TM
    Jean-Antoine Villemin and the infectious nature of tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:267-8.
    PubMed     Text format    


  501. VILLEMIN DJ
    On the virulence and specificity of tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:256-66.
    PubMed     Text format    


  502. HOUBEN RM, White RG
    To improve our tuberculosis burden estimates we need to learn from each other.
    Int J Tuberc Lung Dis. 2015;19:255.
    PubMed     Text format    


  503. O'GRADY J, Kik SV, Ferrara G
    Extra-pulmonary tuberculosis and Xpert((R)) MTB/RIF: all about meta-analyses?
    Int J Tuberc Lung Dis. 2015;19:254.
    PubMed     Text format    


  504. STEINGART KR, Schiller I, Dendukuri N
    In reply to 'False-positive Xpert(R) MTB/RIF assays in previously treated patients'.
    Int J Tuberc Lung Dis. 2015;19:366-7.
    PubMed     Text format    


  505. HOGER S, Lykens K, Beavers S, Katz D, et al
    In reply.
    Int J Tuberc Lung Dis. 2015;19:367-8.
    PubMed     Text format    


  506. ZHANG H, Zhang JQ, Zhong XN, Liu GN, et al
    Two case reports of Castleman disease with pulmonary involvement.
    Int J Tuberc Lung Dis. 2015;19:362-5.
    PubMed     Text format     Abstract available


  507. PARK SJ, Jo KW, Yoo B, Lee CK, et al
    Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.
    Int J Tuberc Lung Dis. 2015;19:342-8.
    PubMed     Text format     Abstract available


  508. WANG HF, Wang R, O'Gorman M, Crownover P, et al
    Bioequivalence of fixed-dose combination RIN(R)-150 to each reference drug in loose combination.
    Int J Tuberc Lung Dis. 2015;19:333-8.
    PubMed     Text format     Abstract available


  509. MOYENGA I, Roggi A, Sulis G, Diande S, et al
    The impact of Xpert(R) MTB/RIF depends on service coordination: experience in Burkina Faso.
    Int J Tuberc Lung Dis. 2015;19:285-7.
    PubMed     Text format     Abstract available


  510. BOYLES TH, Thwaites GE
    Appropriate use of the Xpert(R) MTB/RIF assay in suspected tuberculous meningitis.
    Int J Tuberc Lung Dis. 2015;19:276-7.
    PubMed     Text format     Abstract available


  511. LIPPINCOTT CK, Miller MB, Van Rie A, Weber DJ, et al
    The complexities of Xpert(R) MTB/RIF interpretation.
    Int J Tuberc Lung Dis. 2015;19:273-5.
    PubMed     Text format     Abstract available


  512. RIEDER HL
    Jean-Antoine Villemin: ending an Alpine divide.
    Int J Tuberc Lung Dis. 2015;19:253.
    PubMed     Text format    


    February 2015
  513. DESHMUKH R
    Breaking down barriers to adherence to standards of tuberculosis care.
    Int J Tuberc Lung Dis. 2015;19:251.
    PubMed     Text format    


  514. KONSTANTINOS A
    Mass treatment to eliminate tuberculosis from an island population.
    Int J Tuberc Lung Dis. 2015;19:251-2.
    PubMed     Text format    


  515. SAFDAR N, Zahid R, Shah S, Fatima R, et al
    Tuberculosis patients learning about second-hand smoke (TBLASS): results of a pilot randomised controlled trial.
    Int J Tuberc Lung Dis. 2015;19:237-43.
    PubMed     Text format     Abstract available


  516. EVANS TB, Mador MJ, Glick M, Ahmad I, et al
    Tuberculosis misclassification among resettled refugees in Buffalo, New York, USA.
    Int J Tuberc Lung Dis. 2015;19:231-6.
    PubMed     Text format     Abstract available


  517. GAO XF, Rao Y
    Quality of life of a migrant population with tuberculosis in West China.
    Int J Tuberc Lung Dis. 2015;19:223-30.
    PubMed     Text format     Abstract available



  518. Market assessment of tuberculosis diagnostics in South Africa, 2012-2013.
    Int J Tuberc Lung Dis. 2015;19:216-22.
    PubMed     Text format     Abstract available


  519. MAH A, Kharrat H, Ahmed R, Gao Z, et al
    Serum drug concentrations of INH and RMP predict 2-month sputum culture results in tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:210-5.
    PubMed     Text format     Abstract available


  520. MECHAI F, Figoni J, Wyplosz B, Aoun O, et al
    Survey of French physician practices in treatment and control of transmission of smear-positive tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:205-9.
    PubMed     Text format     Abstract available


  521. LEE K, Chung W, Jung Y, Kim Y, et al
    CXCR3 ligands as clinical markers for pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:191-9.
    PubMed     Text format     Abstract available


  522. VAN DEUN A, Aung KJ, Hossain A, de Rijk P, et al
    Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:185-90.
    PubMed     Text format     Abstract available


  523. AKHMETOVA A, Kozhamkulov U, Bismilda V, Chingissova L, et al
    Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
    Int J Tuberc Lung Dis. 2015;19:179-84.
    PubMed     Text format     Abstract available


  524. SINANOVIC E, Ramma L, Vassall A, Azevedo V, et al
    Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.
    Int J Tuberc Lung Dis. 2015;19:172-8.
    PubMed     Text format     Abstract available



  525. Nationwide survey of anti-tuberculosis drug resistance in Japan.
    Int J Tuberc Lung Dis. 2015;19:157-62.
    PubMed     Text format     Abstract available


  526. KAMAL SM, Hossain A, Sultana S, Begum V, et al
    Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey.
    Int J Tuberc Lung Dis. 2015;19:151-6.
    PubMed     Text format     Abstract available


  527. CRANMER LM, Kanyugo M, Lohman-Payne B, Tapia K, et al
    Tuberculosis interferon-gamma responses in the breast milk of human immunodeficiency virus infected mothers.
    Int J Tuberc Lung Dis. 2015;19:141-3.
    PubMed     Text format     Abstract available


  528. ANDREWS JR, Stout JE
    Treating multidrug-resistant tuberculosis in community settings: a wise investment.
    Int J Tuberc Lung Dis. 2015;19:127.
    PubMed     Text format    


  529. SOLOMONS RS, Goussard P, Visser DH, Marais BJ, et al
    Chest radiograph findings in children with tuberculous meningitis.
    Int J Tuberc Lung Dis. 2015;19:200-4.
    PubMed     Text format     Abstract available


  530. LOVEDAY M, Wallengren K, Brust J, Roberts J, et al
    Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2015;19:163-71.
    PubMed     Text format     Abstract available


  531. COLEMAN M, Finney LJ, Komrower D, Chitani A, et al
    Markers to differentiate between Kaposi's sarcoma and tuberculous pleural effusions in HIV-positive patients.
    Int J Tuberc Lung Dis. 2015;19:144-50.
    PubMed     Text format     Abstract available


  532. DENHOLM JT, Matteelli A, Reis A
    Latent tuberculous infection: ethical considerations in formulating public health policy.
    Int J Tuberc Lung Dis. 2015;19:137-40.
    PubMed     Text format     Abstract available


    January 2015
  533. YAMANA H, Matsui H, Fushimi K, Yasunaga H, et al
    Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study.
    Int J Tuberc Lung Dis. 2015;19:120-6.
    PubMed     Text format     Abstract available


  534. VOLKMANN T, Moonan PK, Miramontes R, Oeltmann JE, et al
    Tuberculosis and excess alcohol use in the United States, 1997-2012.
    Int J Tuberc Lung Dis. 2015;19:111-9.
    PubMed     Text format     Abstract available


  535. MCLAREN ZM, Brouwer E, Ederer D, Fischer K, et al
    Gender patterns of tuberculosis testing and disease in South Africa.
    Int J Tuberc Lung Dis. 2015;19:104-10.
    PubMed     Text format     Abstract available


  536. LORENT N, Buyze J, Kim T, Kong C, et al
    Is frontloaded sputum microscopy an option in active tuberculosis case finding?
    Int J Tuberc Lung Dis. 2015;19:91-6.
    PubMed     Text format     Abstract available


  537. KIM YW, Kwak N, Seong MW, Kim EC, et al
    Accuracy of the Xpert((R)) MTB/RIF assay for the diagnosis of extra-pulmonary tuberculosis in South Korea.
    Int J Tuberc Lung Dis. 2015;19:81-6.
    PubMed     Text format     Abstract available


  538. OLARU ID, Rachow A, Lange C, Ntinginya NE, et al
    Ascertaining in vivo virulence of Mycobacterium tuberculosis lineages in patients in Mbeya, Tanzania.
    Int J Tuberc Lung Dis. 2015;19:70-3.
    PubMed     Text format     Abstract available


  539. ARNEDO-PENA A, Juan-Cerdan JV, Romeu-Garcia A, Garcia-Ferrer D, et al
    Vitamin D status and incidence of tuberculosis among contacts of pulmonary tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:65-9.
    PubMed     Text format     Abstract available


  540. FAN WC, Liu CJ, Hong YC, Feng JY, et al
    Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.
    Int J Tuberc Lung Dis. 2015;19:58-64.
    PubMed     Text format     Abstract available


  541. COLLINS SE, Jean Juste MA, Koenig SP, Secours R, et al
    CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.
    Int J Tuberc Lung Dis. 2015;19:50-7.
    PubMed     Text format     Abstract available


  542. BROUWER M, Coelho E, das Dores Mosse C, van Leth F, et al
    Implementation of tuberculosis infection prevention and control in Mozambican health care facilities.
    Int J Tuberc Lung Dis. 2015;19:44-9.
    PubMed     Text format     Abstract available


  543. REID A, Grant AD, White RG, Dye C, et al
    Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention.
    Int J Tuberc Lung Dis. 2015;19:5-9.
    PubMed     Text format     Abstract available


  544. LAWN SD
    Preventing HIV-associated tuberculosis with antiretroviral therapy: shut the stable door early!
    Int J Tuberc Lung Dis. 2015;19:3-4.
    PubMed     Text format    


  545. SCHUMACHER SG, Pai M
    Xpert((R)) MTB/RIF for extra-pulmonary tuberculosis: time to look beyond accuracy.
    Int J Tuberc Lung Dis. 2015;19:2.
    PubMed     Text format    


  546. ZISHIRI V, Chihota V, McCarthy K, Charalambous S, et al
    Pooling sputum from multiple individuals for Xpert(R) MTB/RIF testing: a strategy for screening high-risk populations.
    Int J Tuberc Lung Dis. 2015;19:87-90.
    PubMed     Text format     Abstract available


  547. SOLOMONS RS, Visser DH, Friedrich SO, Diacon AH, et al
    Improved diagnosis of childhood tuberculous meningitis using more than one nucleic acid amplification test.
    Int J Tuberc Lung Dis. 2015;19:74-80.
    PubMed     Text format     Abstract available


  548. YUEN CM, Krapivina TM, Kazennyy BY, Kiryanova EV, et al
    Annual risk of tuberculous infection measured using serial skin testing, Orel Oblast, Russia, 1991-2005.
    Int J Tuberc Lung Dis. 2015;19:39-43.
    PubMed     Text format     Abstract available


  549. HIRSCH-MOVERMAN Y, Shrestha-Kuwahara R, Bethel J, Blumberg HM, et al
    Latent tuberculous infection in the United States and Canada: who completes treatment and why?
    Int J Tuberc Lung Dis. 2015;19:31-8.
    PubMed     Text format     Abstract available


    December 2014
  550. SHARMA P, Sharma K, Singh D, Verma S, et al
    Failure of the MGIT(TM) 960 culture system in the detection of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2014;18:1525.
    PubMed     Text format    


  551. ATRE S
    Private players in tuberculosis control: will negotiation help to maintain the symbiosis in the ecosystem?
    Int J Tuberc Lung Dis. 2014;18:1524-6.
    PubMed     Text format    


  552. ADADA H, Valley MA, Nour SA, Mehta J, et al
    Epidemiology of extra-pulmonary tuberculosis in the United States: high rates persist in the post-HIV era.
    Int J Tuberc Lung Dis. 2014;18:1516-21.
    PubMed     Text format     Abstract available


  553. LOPES MA, Ferracioli KR, Siqueira VL, de Lima Scodro RB, et al
    In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2014;18:1513-5.
    PubMed     Text format     Abstract available


  554. BISHARA H, Rorman E, Mor Z, Shechter-Amram D, et al
    Tuberculosis Beijing strain outbreak in an Israeli Arab rural community linked to an incarcerated immigrant.
    Int J Tuberc Lung Dis. 2014;18:1502-4.
    PubMed     Text format     Abstract available


  555. LIU F, Du FJ, Jia HY, Pan LP, et al
    Inadequate values from an interferon-gamma release assay for smear-negative tuberculosis in a high-burden setting.
    Int J Tuberc Lung Dis. 2014;18:1496-501.
    PubMed     Text format     Abstract available


  556. CHADHA VK, Praseeja P, Hemanthkumar NK, Shivshankara BA, et al
    Are registered sputum smear-negative tuberculosis patients in Karnataka, India, diagnosed by national algorithm?
    Int J Tuberc Lung Dis. 2014;18:1491-5.
    PubMed     Text format     Abstract available


  557. WU YC, Lo HY, Yang SL, Chou P, et al
    Factors correlated with tuberculosis reported after death.
    Int J Tuberc Lung Dis. 2014;18:1485-90.
    PubMed     Text format     Abstract available


  558. FURIN J, Isaakidis P, Reid AJ, Kielmann K, et al
    'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV.
    Int J Tuberc Lung Dis. 2014;18:1479-84.
    PubMed     Text format     Abstract available


  559. PACHECO AG, Veloso VG, Nunes EP, Ribeiro S, et al
    Tuberculosis is associated with non-tuberculosis-related deaths among HIV/AIDS patients in Rio de Janeiro.
    Int J Tuberc Lung Dis. 2014;18:1473-8.
    PubMed     Text format     Abstract available


  560. KANCHEYA N, Luhanga D, Harris JB, Morse J, et al
    Integrating active tuberculosis case finding in antenatal services in Zambia.
    Int J Tuberc Lung Dis. 2014;18:1466-72.
    PubMed     Text format     Abstract available


  561. JIMENEZ-FUENTES MA, Auge CM, Gomez MN, Peiro JS, et al
    Screening for active tuberculosis in high-risk groups.
    Int J Tuberc Lung Dis. 2014;18:1459-65.
    PubMed     Text format     Abstract available


  562. CHADHA VK, Praseeja P, Gupta J, Ahmed J, et al
    A descriptive study of tuberculosis case finding in private health care facilities in a South Indian district.
    Int J Tuberc Lung Dis. 2014;18:1455-8.
    PubMed     Text format     Abstract available


  563. RUBINOWICZ A, Bartlett G, MacGibbon B, Greenaway C, et al
    Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study.
    Int J Tuberc Lung Dis. 2014;18:1449-54.
    PubMed     Text format     Abstract available


  564. AZADI M, Bishai DM, Dowdy DW, Moulton LH, et al
    Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
    Int J Tuberc Lung Dis. 2014;18:1443-8.
    PubMed     Text format     Abstract available


  565. CAMPBELL IA, Chaudhary RD, Holdsworth GM, Lyne OD, et al
    Brief advice to tuberculosis patients in Nepal to stop smoking: a pilot study by the Britain Nepal Medical Trust.
    Int J Tuberc Lung Dis. 2014;18:1438-42.
    PubMed     Text format     Abstract available


  566. KOHLER S, Asadov DA, Brunder A, Healy S, et al
    Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms.
    Int J Tuberc Lung Dis. 2014;18:1390-5.
    PubMed     Text format     Abstract available


  567. SOTGIU G, Gegia M, Migliori GB
    Extra-pulmonary tuberculosis: the comorbidity of the near future?
    Int J Tuberc Lung Dis. 2014;18:1389.
    PubMed     Text format    


    November 2014
  568. FRICK M, Seaworth B, McKenna L, Elnour T, et al
    Cost-effectiveness of 12-dose LTBI regimen improved following advocacy to lower the price of rifapentine.
    Int J Tuberc Lung Dis. 2014;18:1386.
    PubMed     Text format    


    August 2014
  569. MARTINSON NA, McLeod KE, Milovanovic M, Msandiwa R, et al
    Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
    Int J Tuberc Lung Dis. 2014;18:1005.
    PubMed     Text format    


  570. SANTUCCI N, Diaz A, Bianchi E, Spinelli S, et al
    Leptin does not enhance cell-mediated immune responses following mycobacterial antigen stimulation.
    Int J Tuberc Lung Dis. 2014;18:981-7.
    PubMed     Text format     Abstract available


  571. MAREKOVIC I, Bosnjak Z, Plecko V
    Direct identification of mycobacteria from smear-positive samples using real-time polymerase chain reaction.
    Int J Tuberc Lung Dis. 2014;18:978-80.
    PubMed     Text format     Abstract available


  572. SHIVARAMAKRISHNA HR, Frederick A, Shazia A, Murali L, et al
    Isoniazid preventive treatment in children in two districts of South India: does practice follow policy?
    Int J Tuberc Lung Dis. 2014;18:919-24.
    PubMed     Text format     Abstract available


  573. BAMRAH S, Brostrom R, Dorina F, Setik L, et al
    Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.
    Int J Tuberc Lung Dis. 2014;18:912-8.
    PubMed     Text format     Abstract available


  574. BONFIGLIOLI KR, Ribeiro AC, Moraes JC, Saad CG, et al
    LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area.
    Int J Tuberc Lung Dis. 2014;18:905-11.
    PubMed     Text format     Abstract available


    July 2014
  575. BOYLES TH, Hughes J, Cox V, Burton R, et al
    False-positive Xpert(R) MTB/RIF assays in previously treated patients: need for caution in interpreting results.
    Int J Tuberc Lung Dis. 2014;18:876-8.
    PubMed     Text format     Abstract available


  576. BANSAL AK, Kulshrestha N, Nagaraja SB, Rade K, et al
    Composite indicator: new tool for monitoring RNTCP performance in India.
    Int J Tuberc Lung Dis. 2014;18:840-2.
    PubMed     Text format     Abstract available


  577. CARUGATI M, Schiroli C, Zanini F, Vanoni N, et al
    A new predictive model for an improved respiratory isolation strategy in HIV-infected patients with PTB.
    Int J Tuberc Lung Dis. 2014;18:831-6.
    PubMed     Text format     Abstract available


  578. SCHWARTZ IS, Bach PJ, Roscoe B, Majury A, et al
    Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates.
    Int J Tuberc Lung Dis. 2014;18:787-92.
    PubMed     Text format     Abstract available


  579. RIEDER HL
    Ninety years after The Magic Mountain: world literature inspired by a misdiagnosis, a tribute to Christian Virchow.
    Int J Tuberc Lung Dis. 2014;18:761-2.
    PubMed     Text format    


    June 2014
  580. CRUZ-FERRO E, Ursua-Diaz MI, Taboada-Rodriguez JA, Hervada-Vidal X, et al
    In reply.
    Int J Tuberc Lung Dis. 2014;18:752-3.
    PubMed     Text format    


  581. SHEPARDSON D, MacKenzie WR
    Update on cost-effectiveness of a 12-dose regimen for latent tuberculous infection at new rifapentine prices.
    Int J Tuberc Lung Dis. 2014;18:751.
    PubMed     Text format    


  582. KIM YK, Hahn S, Uh Y, Im DJ, et al
    Comparable characteristics of tuberculous and non-tuberculous mycobacterial cavitary lung diseases.
    Int J Tuberc Lung Dis. 2014;18:725-9.
    PubMed     Text format     Abstract available


  583. AICHELBURG MC, Mandorfer M, Tittes J, Breitenecker F, et al
    The association of smoking with IGRA and TST results in HIV-1-infected subjects.
    Int J Tuberc Lung Dis. 2014;18:709-16.
    PubMed     Text format     Abstract available


  584. SHIBOSKI CH, Chen H, Ghannoum MA, Komarow L, et al
    Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.
    Int J Tuberc Lung Dis. 2014;18:682-8.
    PubMed     Text format     Abstract available


    May 2014
  585. PUTRI FA, Burhan E, Nawas A, Soepandi PZ, et al
    Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Int J Tuberc Lung Dis. 2014;18:564-70.
    PubMed     Text format     Abstract available


  586. AMLABU V, Mulligan C, Jele N, Evans A, et al
    Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children.
    Int J Tuberc Lung Dis. 2014;18:528-30.
    PubMed     Text format     Abstract available


  587. LANIADO-LABORIN R, Cazares-Adame R, Volker-Soberanes ML, del Portillo-Mustieles C, et al
    Latent tuberculous infection prevalence among paediatric contacts of drug-resistant and drug-susceptible cases.
    Int J Tuberc Lung Dis. 2014;18:515-9.
    PubMed     Text format     Abstract available


    April 2014
  588. KALITA J, Prasad S, Misra UK
    Predictors of paradoxical tuberculoma in tuberculous meningitis.
    Int J Tuberc Lung Dis. 2014;18:486-91.
    PubMed     Text format     Abstract available


  589. HUANG ZK, Luo Q, Xiong GL, Li WT, et al
    Evaluation of indirect drug susceptibility testing using the MODS assay for the detection of XDR-TB in China.
    Int J Tuberc Lung Dis. 2014;18:461-5.
    PubMed     Text format     Abstract available


  590. PAGE-SHIPP L, Stevens W, Clark D, Scott L, et al
    Successes, challenges and lessons from a novel deployment of Xpert((R)) MTB/RIF at a major South African public event [Short Communication].
    Int J Tuberc Lung Dis. 2014;18:438-40.
    PubMed     Text format     Abstract available


  591. JUNG YJ, Lee JY, Jo KW, Yoo B, et al
    The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment.
    Int J Tuberc Lung Dis. 2014;18:428-34.
    PubMed     Text format     Abstract available


  592. FISKE CT, Yan FX, Hirsch-Moverman Y, Sterling TR, et al
    Risk factors for treatment default in close contacts with latent tuberculous infection.
    Int J Tuberc Lung Dis. 2014;18:421-7.
    PubMed     Text format     Abstract available


  593. ERKENS CG, Dinmohamed AG, Kamphorst M, Toumanian S, et al
    Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.
    Int J Tuberc Lung Dis. 2014;18:413-20.
    PubMed     Text format     Abstract available


  594. LALA SG, Parbhoo KB, Verwey C, Khan R, et al
    The effect of topical calcipotriol or zinc on tuberculin skin tests in hospitalised South African children.
    Int J Tuberc Lung Dis. 2014;18:388-93.
    PubMed     Text format     Abstract available


  595. WHITE RG, Houben RM
    Towards elimination in industrialised countries: expanding diagnosis and treatment of LTBI among immigrants.
    Int J Tuberc Lung Dis. 2014;18:380.
    PubMed     Text format    


  596. VAN LETH F, Kampmann B
    Embracing the challenges of HIV-TB co-infection in children.
    Int J Tuberc Lung Dis. 2014;18:379.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: